Identification	O
of	O
a	O
major	O
positive	B-DNA
regulatory	I-DNA
element	I-DNA
located	O
5	O
'	O
to	O
the	O
human	B-DNA
zeta-globin	I-DNA
gene	I-DNA
.	O

The	O
function	O
of	O
the	O
zeta-globin	B-DNA
promoter	I-DNA
was	O
studied	O
using	O
a	O
series	O
of	O
zeta-globin	B-DNA
promoter	I-DNA
deletion	I-DNA
constructs	I-DNA
to	O
drive	O
luciferase	B-protein
expression	O
in	O
transiently	B-cell_line
transfected	I-cell_line
human	I-cell_line
erythroleukemia	I-cell_line
cells	I-cell_line
.	O

The	O
promoters	B-DNA
were	O
used	O
without	O
enhancers	B-DNA
,	O
or	O
with	O
enhancers	B-DNA
derived	O
from	O
the	O
beta-globin	B-DNA
locus	I-DNA
control	I-DNA
region	I-DNA
and	O
the	O
alpha-globin	B-DNA
HS-40	I-DNA
enhancer	I-DNA
.	O

When	O
transfected	O
into	O
K562	B-cell_line
cells	I-cell_line
,	O
which	O
express	O
zeta-globin	B-protein
,	O
comparable	O
amounts	O
of	O
activity	O
were	O
obtained	O
from	O
the	O
-557	B-DNA
and	I-DNA
-417	I-DNA
zeta-luciferase	I-DNA
constructs	I-DNA
and	O
the	O
alpha-luciferase	B-DNA
constructs	I-DNA
when	O
no	O
enhancers	B-DNA
or	O
the	O
alpha-globin	B-DNA
locus	I-DNA
enhancers	I-DNA
were	O
used	O
.	O

When	O
the	O
constructs	O
were	O
transfected	O
into	O
OCIM1	B-cell_line
cells	I-cell_line
,	O
which	O
do	O
not	O
express	O
zeta-globin	B-protein
,	O
the	O
zeta-globin	B-DNA
promoters	I-DNA
were	O
at	O
best	O
20	O
%	O
as	O
active	O
as	O
the	O
alpha-globin	B-DNA
promoters	I-DNA
.	O

When	O
sequences	B-DNA
from	I-DNA
-417	I-DNA
to	I-DNA
-207	I-DNA
5	I-DNA
'	I-DNA
to	O
the	O
zeta-globin	B-RNA
mRNA	I-RNA
cap	I-RNA
site	I-RNA
were	O
deleted	O
,	O
up	O
to	O
95	O
%	O
of	O
the	O
zeta-globin	B-DNA
promoter	I-DNA
activity	O
was	O
lost	O
in	O
K562	B-cell_line
cells	I-cell_line
.	O

Reinsertion	O
of	O
these	O
sequences	O
into	O
zeta-luciferase	B-DNA
constructs	I-DNA
missing	O
the	O
-417	O
to	O
-207	O
region	O
showed	O
that	O
the	O
sequences	O
lack	O
classical	O
enhancer	O
activity	O
.	O

Point	O
mutation	O
of	O
a	O
GATA-1	B-DNA
site	I-DNA
at	O
-230	O
reduced	O
promoter	O
activity	O
by	O
37	O
%	O
.	O

Point	O
mutation	O
of	O
a	O
CCACC	B-DNA
site	I-DNA
at	O
-240	O
had	O
no	O
effect	O
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
indicated	O
that	O
the	O
-230	B-DNA
GATA-1	I-DNA
site	I-DNA
has	O
a	O
relatively	O
low	O
affinity	O
for	O
GATA-1	B-protein
.	O

These	O
experiments	O
show	O
the	O
presence	O
of	O
a	O
strong	O
positive-acting	B-DNA
element	I-DNA
,	O
located	O
between	O
-417	B-DNA
and	I-DNA
-207	I-DNA
bp	I-DNA
5	I-DNA
'	I-DNA
to	O
the	O
zeta-globin	B-DNA
mRNA	I-DNA
cap	I-DNA
site	I-DNA
,	O
is	O
necessary	O
for	O
high-level	O
promoter	O
activity	O
in	O
K562	B-cell_line
cells	I-cell_line
.	O

This	O
element	O
requires	O
GATA-1	B-protein
and	O
additional	B-protein
unknown	I-protein
factors	I-protein
for	O
maximal	O
activity	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
Major	NULL
Positive	NULL
Regulatory	NULL
Element	NULL
Located	NULL
5	NULL
'	NULL
to	NULL
the	NULL
Human	NULL
{	NULL
-Globin	NULL
Gene	NULL
By	NULL
Daniel	NULL
E.	NULL
Sabath	NULL
,	NULL
Karen	NULL
M.	NULL
Koehler	NULL
,	NULL
Wei-Qing	NULL
Yang	NULL
,	NULL
Kathryn	NULL
Patton	NULL
,	NULL
and	NULL
George	NULL
Stamatoyannopoulos	NULL
The	NULL
function	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
was	NULL
studied	NULL
using	NULL
a	NULL
series	NULL
of	NULL
{	NULL
-globin	NULL
promoter	NULL
deletion	NULL
constructs	NULL
to	NULL
drive	NULL
luciferase	NULL
expression	NULL
in	NULL
transiently	NULL
transfected	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

The	NULL
promoters	NULL
were	NULL
used	NULL
without	NULL
enhancers	NULL
,	NULL
or	NULL
with	NULL
enhancers	NULL
derived	NULL
from	NULL
the	NULL
-globin	NULL
locus	NULL
control	NULL
region	NULL
and	NULL
the	NULL
a-globin	NULL
HS-40	NULL
enhancer	NULL
.	NULL

When	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
{	NULL
-globin	NULL
,	NULL
comparable	NULL
amounts	NULL
of	NULL
activity	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
-557	NULL
and	NULL
-417	NULL
t-luciferase	NULL
constructs	NULL
and	NULL
the	NULL
a-luciferase	NULL
constructs	NULL
when	NULL
no	NULL
enhancers	NULL
or	NULL
the	NULL
a-globin	NULL
locus	NULL
enhancers	NULL
were	NULL
used	NULL
.	NULL

When	NULL
the	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
OCIM1	NULL
cells	NULL
,	NULL
which	NULL
do	NULL
not	NULL
express	NULL
(	NULL
-globin	NULL
,	NULL
the	NULL
{	NULL
-globin	NULL
promoters	NULL
were	NULL
at	NULL
best	NULL
20	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
«	NULL
-globin	NULL
promoters	NULL
.	NULL

When	NULL
sequences	NULL
from	NULL
-417	NULL
to	NULL
-207	NULL
5	NULL
'	NULL
to	NULL
the	NULL
{	NULL
-globin	NULL
mRNA	NULL
cap	NULL
-GLOBIN	NULL
IS	NULL
THE	NULL
EMBRYONIC	NULL
FORM	NULL
of	NULL
a-globin	NULL
;	NULL
its	NULL
expression	NULL
is	NULL
confined	NULL
to	NULL
yolk	NULL
sac-derived	NULL
primitive	NULL
erythroid	NULL
cells	NULL
.	NULL

Transgenic	NULL
mice	NULL
containing	NULL
the	NULL
human	NULL
&	NULL
-globin	NULL
gene	NULL
express	NULL
the	NULL
gene	NULL
in	NULL
a	NULL
developmentally	NULL
correct	NULL
fashion	NULL
,	NULL
even	NULL
if	NULL
as	NULL
little	NULL
as	NULL
128	NULL
bp	NULL
of	NULL
the	NULL
&	NULL
-globin	NULL
proximal	NULL
promoter	NULL
is	NULL
present	NULL
.	NULL
``	NULL

''	NULL
The	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
-globin	NULL
gene	NULL
is	NULL
sufficient	NULL
for	NULL
developmentally	NULL
correct	NULL
expression	NULL
,	NULL
because	NULL
transgenic	NULL
mice	NULL
containing	NULL
bacterial	NULL
3-galactosidase	NULL
under	NULL
control	NULL
of	NULL
the	NULL
E-globin	NULL
promoter	NULL
express	NULL
3-galactosidase	NULL
only	NULL
in	NULL
the	NULL
embryonic	NULL
yolk	NULL
sac	NULL
.	NULL

Some	NULL
investigators	NULL
have	NULL
shown	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
within	NULL
the	NULL
E-globin	NULL
promoter	NULL
,	NULL
*	NULL
``	NULL
but	NULL
in	NULL
contrast	NULL
with	NULL
the	NULL
embryonic	NULL
B-like	NULL
globin	NULL
gene	NULL
,	NULL
e	NULL
,	NULL
no	NULL
developmental	NULL
silencer	NULL
has	NULL
been	NULL
detected	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
gene	NULL
.	NULL

``	NULL
**	NULL
While	NULL
transgenic	NULL
mouse	NULL
experiments	NULL
have	NULL
been	NULL
useful	NULL
for	NULL
showing	NULL
qualitative	NULL
function	NULL
of	NULL
the	NULL
-globin	NULL
promoter	NULL
,	NULL
it	NULL
has	NULL
not	NULL
been	NULL
possible	NULL
to	NULL
quantitate	NULL
promoter	NULL
activity	NULL
in	NULL
transgenic	NULL
mice	NULL
,	NULL
because	NULL
{	NULL
-globin	NULL
transgene	NULL
expression	NULL
appears	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
the	NULL
site	NULL
of	NULL
integration	NULL
in	NULL
the	NULL
mouse	NULL
genome	NULL
.	NULL
``	NULL

An	NULL
alternate	NULL
method	NULL
for	NULL
studying	NULL
E-globin	NULL
promoter	NULL
function	NULL
is	NULL
to	NULL
transfect	NULL
C-globin	NULL
expression	NULL
constructs	NULL
into	NULL
erythroid	NULL
cell	NULL
lines	NULL
that	NULL
do	NULL
or	NULL
do	NULL
not	NULL
express	NULL
&	NULL
-globin	NULL
.	NULL

Two	NULL
issues	NULL
regarding	NULL
{	NULL
-globin	NULL
promoter	NULL
function	NULL
can	NULL
be	NULL
addressed	NULL
with	NULL
such	NULL
studies	NULL
.	NULL

First	NULL
,	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
necessary	NULL
for	NULL
high-level	NULL
expression	NULL
in	NULL
embryonic	NULL
cells	NULL
can	NULL
be	NULL
identified	NULL
.	NULL

It	NULL
may	NULL
also	NULL
be	NULL
possible	NULL
to	NULL
identify	NULL
negative	NULL
regulatory	NULL
elements	NULL
by	NULL
transfecting	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
express	NULL
C-globin	NULL
.	NULL

A	NULL
negative	NULL
regulatory	NULL
element	NULL
would	NULL
be	NULL
identified	NULL
if	NULL
its	NULL
deletion	NULL
resulted	NULL
in	NULL
increased	NULL
expression	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
positive	NULL
and	NULL
negative	NULL
elements	NULL
overlap	NULL
must	NULL
be	NULL
considered	NULL
as	NULL
well	NULL
.	NULL

Besides	NULL
the	NULL
function	NULL
of	NULL
the	NULL
promoter	NULL
itself	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
enhancer	NULL
sequences	NULL
are	NULL
necessary	NULL
for	NULL
E-globin	NULL
expression	NULL
,	NULL
and	NULL
if	NULL
so	NULL
,	NULL
what	NULL
regions	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
promoter	NULL
mediate	NULL
this	NULL
interaction	NULL
.	NULL

A	NULL
number	NULL
of	NULL
structure-function	NULL
studies	NULL
have	NULL
been	NULL
performed	NULL
on	NULL
the	NULL
-globin	NULL
promoter	NULL
,	NULL
some	NULL
with	NULL
conflicting	NULL
con-clusions	NULL
.	NULL

Early	NULL
transient	NULL
transfection	NULL
studies	NULL
of	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
cells	NULL
suggested	NULL
there	NULL
was	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
5°	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
-globin	NULL
gene	NULL
.	NULL

*	NULL
``	NULL
However	NULL
,	NULL
these	NULL
studies	NULL
were	NULL
hampered	NULL
by	NULL
poor	NULL
sensitivity	NULL
because	NULL
erythroid-specific	NULL
enhancer	NULL
elements	NULL
,	NULL
which	NULL
had	NULL
not	NULL
Blood	NULL
,	NULL
Vol	NULL
85	NULL
,	NULL
No	NULL
8	NULL
(	NULL
May	NULL
1	NULL
}	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
2587-2597	NULL
site	NULL
were	NULL
deleted	NULL
,	NULL
up	NULL
to	NULL
95	NULL
%	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
activity	NULL
was	NULL
lost	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

Reinsertion	NULL
of	NULL
these	NULL
sequences	NULL
into	NULL
{	NULL
-luciferase	NULL
constructs	NULL
missing	NULL
the	NULL
-417	NULL
to	NULL
-207	NULL
region	NULL
showed	NULL
that	NULL
the	NULL
sequences	NULL
lack	NULL
classical	NULL
enhancer	NULL
activity	NULL
.	NULL

Point	NULL
mutation	NULL
of	NULL
a	NULL
GATA-1	NULL
site	NULL
at	NULL
-230	NULL
reduced	NULL
promoter	NULL
activity	NULL
by	NULL
37	NULL
%	NULL
.	NULL

Point	NULL
mutation	NULL
of	NULL
a	NULL
CCACC	NULL
site	NULL
at	NULL
-240	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
indicated	NULL
that	NULL
the	NULL
-230	NULL
GATA-1	NULL
site	NULL
has	NULL
a	NULL
relatively	NULL
low	NULL
affinity	NULL
for	NULL
GATA-1	NULL
.	NULL

These	NULL
experiments	NULL
show	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
strong	NULL
posi-tive-acting	NULL
element	NULL
,	NULL
located	NULL
between	NULL
-417	NULL
and	NULL
-207	NULL
bp	NULL
5	NULL
to	NULL
the	NULL
{	NULL
-globin	NULL
mRNA	NULL
cap	NULL
site	NULL
,	NULL
is	NULL
necessary	NULL
for	NULL
high-level	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

This	NULL
element	NULL
requires	NULL
GATA-1	NULL
and	NULL
additional	NULL
unknown	NULL
factors	NULL
for	NULL
maximal	NULL
activity	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

been	NULL
characterized	NULL
at	NULL
that	NULL
time	NULL
,	NULL
were	NULL
not	NULL
used	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
some	NULL
of	NULL
these	NULL
experiments	NULL
used	NULL
nonerythroid	NULL
cells	NULL
to	NULL
identify	NULL
negative	NULL
regulatory	NULL
elements	NULL
;	NULL
these	NULL
elements	NULL
may	NULL
not	NULL
function	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

More	NULL
recent	NULL
experiments	NULL
using	NULL
the	NULL
HS-40	NULL
enhancer'*	NULL
'	NULL
have	NULL
failed	NULL
to	NULL
reproduce	NULL
this	NULL
result	NULL
.	NULL

They	NULL
showed	NULL
instead	NULL
that	NULL
GATA-1	NULL
sites	NULL
at	NULL
-230	NULL
and	NULL
-105	NULL
positively	NULL
regulate	NULL
C	NULL
expression	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
``	NULL
a	NULL
human	NULL
erythroid	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
embryonic	NULL
hemoglobins	NULL
.	NULL

``	NULL
``	NULL
'°	NULL
Stable	NULL
transfection	NULL
of	NULL
{	NULL
-globin	NULL
genes	NULL
into	NULL
murine	NULL
erythroleukemia	NULL
cells	NULL
,	NULL
which	NULL
only	NULL
express	NULL
adult	NULL
globins	NULL
,	NULL
also	NULL
failed	NULL
to	NULL
show	NULL
a	NULL
stage-specific	NULL
silencer	NULL
.	NULL
``	NULL

Because	NULL
of	NULL
the	NULL
sometimes-conflicting	NULL
data	NULL
in	NULL
the	NULL
literature	NULL
regarding	NULL
the	NULL
function	NULL
of	NULL
the	NULL
&	NULL
-globin	NULL
promoter	NULL
,	NULL
we	NULL
have	NULL
performed	NULL
experiments	NULL
to	NULL
answer	NULL
the	NULL
following	NULL
questions	NULL
:	NULL
(	NULL
1	NULL
)	NULL
What	NULL
parts	NULL
of	NULL
the	NULL
promoter	NULL
are	NULL
important	NULL
for	NULL
expression	NULL
in	NULL
embryonic	NULL
erythroid	NULL
cells	NULL
?	NULL

(	NULL
2	NULL
)	NULL
What	NULL
enhancers	NULL
work	NULL
best	NULL
with	NULL
the	NULL
C-globin	NULL
promoter	NULL
,	NULL
and	NULL
what	NULL
elements	NULL
within	NULL
the	NULL
promoter	NULL
interact	NULL
with	NULL
enhancers	NULL
?	NULL

and	NULL
(	NULL
3	NULL
)	NULL
Is	NULL
there	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
within	NULL
the	NULL
C-globin	NULL
promoter	NULL
?	NULL

To	NULL
address	NULL
these	NULL
questions	NULL
,	NULL
we	NULL
have	NULL
used	NULL
luciferase	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
the	NULL
transient	NULL
transfection	NULL
of	NULL
two	NULL
cell	NULL
lines	NULL
with	NULL
different	NULL
patterns	NULL
of	NULL
globin	NULL
expression	NULL
:	NULL
K562	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
erythroid	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
embryonic	NULL
globins	NULL
,	NULL
``	NULL
*	NULL
``	NULL
``	NULL
and	NULL
OCIM	NULL
!	NULL

1	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
erythroid	NULL
line	NULL
that	NULL
does	NULL
not	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
it	NULL
has	NULL
much	NULL
less	NULL
activity	NULL
in	NULL
OCIM1	NULL
cells	NULL
,	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Laboratory	NULL
Medicine	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Medical	NULL
Genetics	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
Submitted	NULL
September	NULL
7	NULL
,	NULL
1994	NULL
;	NULL
accepted	NULL
December	NULL
2	NULL
,	NULL
1994	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
NIH	NULL
)	NULL
Grants	NULL
No	NULL
.	NULL

HL20899	NULL
and	NULL
DK45365	NULL
(	NULL
to	NULL
G.S	NULL
.	NULL
)	NULL

and	NULL
NIH	NULL
training	NULL
Grant	NULL
No	NULL
.	NULL

HLO7312D	NULL
(	NULL
to	NULL
D.E.S	NULL
.	NULL
)	NULL

.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Daniel	NULL
E.	NULL
Sabath	NULL
,	NULL
MD	NULL
,	NULL
PhD	NULL
,	NULL
Department	NULL
of	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
SB-10	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
1959	NULL
NE	NULL
Pacific	NULL
St	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98195	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/95/8509-0035	NULL
$	NULL
%	NULL
3.00/0	NULL
2587	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2588	NULL
we	NULL
show	NULL
that	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
is	NULL
quite	NULL
effective	NULL
at	NULL
driving	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
sequences	NULL
between	NULL
-417	NULL
and	NULL
-207	NULL
,	NULL
designated	NULL
the	NULL
upstream	NULL
regulatory	NULL
region	NULL
(	NULL
URE	NULL
)	NULL
,	NULL
are	NULL
required	NULL
for	NULL
high-level	NULL
E-globin	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
promoter	NULL
functions	NULL
autonomously	NULL
,	NULL
ie	NULL
,	NULL
relative	NULL
promoter	NULL
activity	NULL
is	NULL
independent	NULL
of	NULL
the	NULL
enhancer	NULL
used	NULL
to	NULL
increase	NULL
expression	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
very	NULL
effective	NULL
at	NULL
increasing	NULL
&	NULL
-globin	NULL
promoter	NULL
activity	NULL
,	NULL
the	NULL
URE	NULL
is	NULL
not	NULL
a	NULL
classical	NULL
enhancer	NULL
because	NULL
its	NULL
activity	NULL
is	NULL
posi-tion-	NULL
and	NULL
orientation-dependent	NULL
.	NULL

The	NULL
URE	NULL
contains	NULL
a	NULL
GATA-1	NULL
site	NULL
at	NULL
-230	NULL
,	NULL
but	NULL
GATA-1	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
is	NULL
only	NULL
partially	NULL
responsible	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
URE	NULL
.	NULL

These	NULL
results	NULL
further	NULL
define	NULL
regions	NULL
of	NULL
the	NULL
E-globin	NULL
promoter	NULL
that	NULL
are	NULL
important	NULL
for	NULL
expression	NULL
of	NULL
{	NULL
-globin	NULL
,	NULL
and	NULL
suggest	NULL
that	NULL
novel	NULL
factors	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
regulation	NULL
of	NULL
{	NULL
-globin	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

-	NULL
K562	NULL
cells	NULL
``	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
S.A.	NULL
Jane	NULL
,	NULL
St	NULL
Jude	NULL
Children	NULL
's	NULL
Research	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
mmol/L	NULL
glutamine	NULL
,	NULL
1	NULL
mmol/L	NULL
sodium	NULL
pyruvate	NULL
,	NULL
50	NULL
U/mL	NULL
penicillin	NULL
,	NULL
50	NULL
pg/mL	NULL
streptomycin	NULL
,	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
and	NULL
5	NULL
%	NULL
defined	NULL
calf	NULL
serum	NULL
.	NULL

OCIM1	NULL
cells	NULL
'	NULL
``	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
Th	NULL
.	NULL

Papayannopoulou	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
mmol/L	NULL
glutamine	NULL
,	NULL
47	NULL
2-mercaptoethanol	NULL
,	NULL
50	NULL
U/mL	NULL
penicillin	NULL
,	NULL
50	NULL
ug/mL	NULL
streptomycin	NULL
,	NULL
5	NULL
%	NULL
FCS	NULL
,	NULL
and	NULL
5	NULL
%	NULL
defined	NULL
calf	NULL
serum	NULL
.	NULL

Both	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

Plasmids	NULL
.	NULL

The	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
(	NULL
RSV	NULL
)	NULL
-luciferase	NULL
plasmid	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
,	NULL
designated	NULL
pRSV-Luc	NULL
,	NULL
contains	NULL
a	NULL
3.3-kbp	NULL
Nde	NULL
I-BamHI	NULL
fragment	NULL
isolated	NULL
from	NULL
plasmid	NULL
pRSV/L*	NULL
containing	NULL
the	NULL
RSV	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
promoter	NULL
,	NULL
``	NULL
luciferase	NULL
cDNA	NULL
,	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
small	NULL
t-antigen	NULL
intron	NULL
,	NULL
and	NULL
the	NULL
polyadenyla-tion	NULL
signal	NULL
from	NULL
plasmid	NULL
pSV2	NULL
.	NULL
``	NULL

pRSV/L	NULL
was	NULL
digested	NULL
with	NULL
Nde	NULL
I	NULL
,	NULL
the	NULL
ends	NULL
were	NULL
made	NULL
blunt	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
pUCI19	NULL
that	NULL
had	NULL
been	NULL
digested	NULL
with	NULL
Sma	NULL
I	NULL
and	NULL
BamHL	NULL
The	NULL
plasmid	NULL
designated	NULL
pRSV-LacZ	NULL
contains	NULL
the	NULL
RSV	NULL
LTR	NULL
promoter	NULL
and	NULL
LacZ	NULL
sequences	NULL
from	NULL
plasmid	NULL
pRSV-GGal*	NULL
``	NULL
linked	NULL
to	NULL
the	NULL
SV40	NULL
sequences	NULL
from	NULL
pRSV-Luc	NULL
.	NULL

It	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
a	NULL
4.5-kbp	NULL
Nhel-Dral	NULL
fragment	NULL
from	NULL
pRSV-GGal	NULL
into	NULL
pUC19	NULL
that	NULL
had	NULL
been	NULL
cut	NULL
with	NULL
HinclI	NULL
and	NULL
Xbal	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
cut	NULL
with	NULL
Pst	NULL
L	NULL
,	NULL
the	NULL
ends	NULL
were	NULL
made	NULL
blunt	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
cut	NULL
with	NULL
and	NULL
the	NULL
resulting	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
pRSV-Luc	NULL
that	NULL
had	NULL
the	NULL
RSV	NULL
and	NULL
luciferase	NULL
sequences	NULL
removed	NULL
by	NULL
digestion	NULL
with	NULL
Sma	NULL
I	NULL
and	NULL
HindIII	NULL
.	NULL

All	NULL
globin-luciferase	NULL
constructs	NULL
were	NULL
generated	NULL
by	NULL
subcloning	NULL
promoter	NULL
sequences	NULL
as	NULL
HZindIII-Sal	NULL
I	NULL
fragments	NULL
into	NULL
a	NULL
luciferase	NULL
expression	NULL
cassette	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
cassette	NULL
was	NULL
made	NULL
by	NULL
subcloning	NULL
luciferase	NULL
and	NULL
SV40	NULL
sequences	NULL
from	NULL
pRSV-Luc	NULL
into	NULL
pBluescript	NULL
SK-	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
a	NULL
2.7-kbp	NULL
HindIII-BamHI	NULL
fragment	NULL
.	NULL

The	NULL
HindIII	NULL
site	NULL
was	NULL
removed	NULL
by	NULL
cutting	NULL
with	NULL
HindIII	NULL
,	NULL
making	NULL
the	NULL
ends	NULL
blunt	NULL
,	NULL
and	NULL
religating	NULL
.	NULL

The	NULL
luciferase	NULL
and	NULL
SV40	NULL
sequences	NULL
were	NULL
then	NULL
subcloned	NULL
into	NULL
pUC19	NULL
as	NULL
a	NULL
Sal	NULL
I-BamHI	NULL
fragment	NULL
.	NULL

The	NULL
promoter	NULL
sequences	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
four	NULL
HS2-	NULL
{	NULL
-globin	NULL
deletion	NULL
constructs	NULL
used	NULL
to	NULL
construct	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
Sal	NULL
I	NULL
sites	NULL
of	NULL
the	NULL
constructs	NULL
were	NULL
first	NULL
removed	NULL
by	NULL
cutting	NULL
with	NULL
Sal	NULL
I	NULL
,	NULL
making	NULL
the	NULL
ends	NULL
blunt	NULL
,	NULL
and	NULL
religating	NULL
.	NULL

The	NULL
plasmids	NULL
were	NULL
then	NULL
cut	NULL
with	NULL
Sty	NULL
I	NULL
,	NULL
which	NULL
cuts	NULL
2	NULL
bp	NULL
3	NULL
'	NULL
to	NULL
the	NULL
E-globin	NULL
mRNA	NULL
cap	NULL
site	NULL
,	NULL
the	NULL
ends	NULL
were	NULL
made	NULL
blunt	NULL
,	NULL
and	NULL
synthetic	NULL
Sal	NULL
I	NULL
linkers	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
were	NULL
added	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
Sal	NULL
I	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
fragments	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
luciferase	NULL
expression	NULL
SABATH	NULL
ET	NULL
AL	NULL
cassette	NULL
.	NULL

For	NULL
the	NULL
construct	NULL
,	NULL
an	NULL
EcoRI	NULL
site	NULL
was	NULL
removed	NULL
by	NULL
cutting	NULL
,	NULL
blunting	NULL
,	NULL
and	NULL
religating	NULL
before	NULL
insertion	NULL
into	NULL
the	NULL
luciferase	NULL
cassette	NULL
.	NULL

The	NULL
(	NULL
A	NULL
(	NULL
-417/-207	NULL
)	NULL
construct	NULL
was	NULL
made	NULL
by	NULL
generating	NULL
a	NULL
249-bp	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
product	NULL
from	NULL
plasmid	NULL
using	NULL
sense	NULL
primer	NULL
ACAGG-3	NULL
'	NULL
(	NULL
complementary	NULL
to	NULL
flanking	NULL
plasmid	NULL
sequences	NULL
)	NULL
and	NULL
antisense	NULL
|	NULL
primer	NULL
-	NULL
5-GGGGTACCCTTCCACTTTGTCTCTGGA-TTC-3	NULL
'	NULL
(	NULL
complementary	NULL
to	NULL
E-globin	NULL
sequences	NULL
-415	NULL
to	NULL
-442	NULL
with	NULL
an	NULL
added	NULL
Kpn	NULL
I	NULL
site	NULL
)	NULL
.	NULL

The	NULL
Kpn	NULL
I	NULL
fragment	NULL
from	NULL
this	NULL
PCR	NULL
product	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
£	NULL
(	NULL
-207	NULL
)	NULL
construct	NULL
.	NULL

Enhancerless	NULL
constructs	NULL
were	NULL
derived	NULL
by	NULL
deleting	NULL
the	NULL
HS2	NULL
region	NULL
,	NULL
an	NULL
873-bp	NULL
BamHI	NULL
frag-ment	NULL
.	NULL

``	NULL
*	NULL
For	NULL
fragments	NULL
containing	NULL
the	NULL
micro	NULL
locus	NULL
control	NULL
region	NULL
(	NULL
LCR	NULL
)	NULL
construct	NULL
,	NULL
the	NULL
HindIII-Sal	NULL
I	NULL
&	NULL
promoter	NULL
fragments	NULL
were	NULL
subcloned	NULL
3	NULL
'	NULL
to	NULL
the	NULL
LCR	NULL
sequences	NULL
in	NULL
plasmid	NULL
LAR	NULL
,	NULL
which	NULL
contains	NULL
hypersensitive	NULL
sites	NULL
1	NULL
through	NULL
4	NULL
of	NULL
the	NULL
#	NULL
-globin	NULL
LCR	NULL
as	NULL
a	NULL
2.5-kbp	NULL
Pst	NULL
1-HindIH	NULL
fragment	NULL
in	NULL
pBluescript	NULL
SK-	NULL
.	NULL
``	NULL

The	NULL
internal	NULL
HirdllI	NULL
site	NULL
was	NULL
removed	NULL
by	NULL
cutting	NULL
,	NULL
blunting	NULL
,	NULL
and	NULL
religating	NULL
.	NULL

The	NULL
plasmids	NULL
were	NULL
digested	NULL
with	NULL
EcoRI	NULL
,	NULL
which	NULL
cuts	NULL
5	NULL
'	NULL
to	NULL
the	NULL
LCR	NULL
sequences	NULL
,	NULL
HindIII	NULL
linkers	NULL
were	NULL
added	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
HindIII-Sal	NULL
I	NULL
gLCR-C	NULL
fragments	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
luciferase	NULL
cassette	NULL
.	NULL

The	NULL
constructs	NULL
containing	NULL
HS-40	NULL
were	NULL
made	NULL
by	NULL
blunt-end	NULL
ligation	NULL
of	NULL
the	NULL
1.4-kbp	NULL
HindIII-EcoRl	NULL
genomic	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
HS-40	NULL
core	NULL
enhancer	NULL
``	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
D.R	NULL
.	NULL

Higgs	NULL
,	NULL
University	NULL
of	NULL
Oxford	NULL
,	NULL
Oxford	NULL
,	NULL
UK	NULL
)	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
of	NULL
the	NULL
enhancerless	NULL
{	NULL
-luciferase	NULL
constructs	NULL
.	NULL

The	NULL
uHS-40	NULL
constructs	NULL
containing	NULL
the	NULL
core	NULL
HS-40	NULL
enhancer	NULL
sequences	NULL
``	NULL
were	NULL
made	NULL
with	NULL
a	NULL
307-bp	NULL
PCR	NULL
product	NULL
amplified	NULL
from	NULL
the	NULL
above	NULL
HS-40-containing	NULL
plasmid	NULL
with	NULL
sense	NULL
primer	NULL
5'-AAAGCTTC-GACCCTCTGGAACCTATCAG-3	NULL
'	NULL
and	NULL
antisense	NULL
primer	NULL
5'-AAA-GCTTGCCTGGCTGTGAACACTTTGGG-3	NULL
'	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
synthesized	NULL
on	NULL
a	NULL
DNA	NULL
synthesizer	NULL
(	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
subcloned	NULL
into	NULL
plasmid	NULL
pCR	NULL
(	NULL
In-vitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
then	NULL
isolated	NULL
as	NULL
a	NULL
HindIII	NULL
fragment	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
enhancerless	NULL
C-luciferase	NULL
constructs	NULL
digested	NULL
with	NULL
HindIII	NULL
.	NULL

All	NULL
enhancers	NULL
were	NULL
oriented	NULL
in	NULL
the	NULL
same	NULL
5'-3	NULL
'	NULL
direction	NULL
relative	NULL
to	NULL
the	NULL
{	NULL
-globin	NULL
gene	NULL
as	NULL
they	NULL
are	NULL
on	NULL
chromosomes	NULL
11	NULL
or	NULL
16	NULL
relative	NULL
to	NULL
their	NULL
respective	NULL
globin	NULL
genes	NULL
.	NULL

To	NULL
make	NULL
the	NULL
a-luciferase	NULL
constructs	NULL
,	NULL
the	NULL
5	NULL
``	NULL
end	NULL
of	NULL
the	NULL
human	NULL
a2	NULL
gene	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
1.5-kbp	NULL
Pst	NULL
I	NULL
fragment	NULL
containing	NULL
the	NULL
a2	NULL
gene	NULL
in	NULL
pUC18	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
EM	NULL
.	NULL

Rubin	NULL
,	NULL
Lawrence	NULL
Berkeley	NULL
Laboratory	NULL
,	NULL
Berkeley	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
was	NULL
digested	NULL
with	NULL
Dde	NULL
I	NULL
,	NULL
which	NULL
cuts	NULL
24	NULL
bp	NULL
3	NULL
``	NULL
to	NULL
the	NULL
a2-globin	NULL
mRNA	NULL
cap	NULL
site	NULL
,	NULL
the	NULL
ends	NULL
were	NULL
made	NULL
blunt	NULL
,	NULL
the	NULL
plasmid	NULL
was	NULL
digested	NULL
with	NULL
Pst	NULL
I	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
590-bp	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
pUC19	NULL
that	NULL
had	NULL
been	NULL
digested	NULL
with	NULL
Sma	NULL
I	NULL
and	NULL
Pst	NULL
1	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
,	NULL
the	NULL
ends	NULL
were	NULL
made	NULL
blunt	NULL
,	NULL
Saf	NULL
I	NULL
linkers	NULL
were	NULL
added	NULL
,	NULL
and	NULL
after	NULL
HindIII	NULL
and	NULL
Sai	NULL
I	NULL
digestion	NULL
,	NULL
the	NULL
«	NULL
2-globin	NULL
promoter	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
luciferase	NULL
cassette	NULL
.	NULL

The	NULL
1.4-kbp	NULL
fragment	NULL
containing	NULL
HS-40	NULL
and	NULL
the	NULL
mHS-40	NULL
fragment	NULL
were	NULL
subcloned	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
as	NULL
with	NULL
the	NULL
C-luciferase	NULL
constructs	NULL
.	NULL

HS2	NULL
was	NULL
isolated	NULL
from	NULL
plasmid	NULL
pHS25	NULL
(	NULL
-557	NULL
)	NULL
as	NULL
an	NULL
bp	NULL
BamHI	NULL
fragment	NULL
and	NULL
blunt-end	NULL
ligated	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
.	NULL

The	NULL
uLCR	NULL
construct	NULL
was	NULL
isolated	NULL
from	NULL
plasmid	NULL
pLAR	NULL
as	NULL
a	NULL
BamHI-EcoRI	NULL
fragment	NULL
and	NULL
blunt-end	NULL
ligated	NULL
into	NULL
the	NULL
HindIII	NULL
site	NULL
.	NULL

As	NULL
with	NULL
the	NULL
{	NULL
luciferase	NULL
constructs	NULL
,	NULL
the	NULL
enhancers	NULL
were	NULL
used	NULL
in	NULL
their	NULL
genomic	NULL
orientations	NULL
.	NULL

The	NULL
upstream	NULL
regulatory	NULL
element	NULL
(	NULL
URE	NULL
)	NULL
insertion	NULL
constructs	NULL
were	NULL
made	NULL
by	NULL
modifying	NULL
the	NULL
{	NULL
A	NULL
(	NULL
-417/-207	NULL
)	NULL
construct	NULL
so	NULL
as	NULL
to	NULL
have	NULL
a	NULL
unique	NULL
BamHI	NULL
site	NULL
at	NULL
the	NULL
-417/-207	NULL
deletion	NULL
site	NULL
,	NULL
5	NULL
``	NULL
to	NULL
the	NULL
{	NULL
-globin	NULL
sequences	NULL
,	NULL
or	NULL
3	NULL
'	NULL
to	NULL
the	NULL
SV40	NULL
sequences	NULL
(	NULL
see	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

A	NULL
275-bp	NULL
PCR	NULL
product	NULL
spanning	NULL
-422	NULL
to	NULL
-163	NULL
was	NULL
generated	NULL
using	NULL
the	NULL
sense	NULL
primer	NULL
5-GCTCTAGAGGGTACTGGCATGTGGTTGG-3	NULL
``	NULL
and	NULL
the	NULL
antisense	NULL
primer	NULL
S-CCATCGATCTCCTGTTCCTCTCCTGTGG-3	NULL
'	NULL
,	NULL
The	NULL
PCR	NULL
product	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
Sma	NULL
I	NULL
site	NULL
of	NULL
pUC19	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
digested	NULL
with	NULL
Xbal	NULL
,	NULL
blunted	NULL
,	NULL
and	NULL
BamHI	NULL
linkers	NULL
were	NULL
added	NULL
.	NULL

The	NULL
resulting	NULL
BamHI	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
sense	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

C-GLOBIN	NULL
UPSTREAM	NULL
REGULATORY	NULL
ELEMENT	NULL
K562	NULL
C	NULL
a	NULL
eAy	NULL
B	NULL
G	NULL
ae	NULL
Ay	NULL
B	NULL
asr	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Globin	NULL
mRNA	NULL
expression	NULL
in	NULL
K562	NULL
and	NULL
OCIM1	NULL
cells	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
t-	NULL
»	NULL
2589	NULL
B	NULL
OCIM1	NULL
r—mmzm	NULL
tSSnlue	NULL
f—_	NULL
:	NULL
n	NULL
:	NULL
m	NULL
:	NULL
m	NULL
:	NULL
n	NULL
:	NULL
mnzm	NULL
<	NULL
-200	NULL
rm	NULL
S20ntue	NULL
from	NULL
K562	NULL
(	NULL
lanes	NULL
1	NULL
through	NULL
5	NULL
)	NULL
or	NULL
OCIM1	NULL
cells	NULL
(	NULL
lanes	NULL
aar	NULL
6	NULL
through	NULL
10	NULL
)	NULL
were	NULL
hybridized	NULL
to	NULL
10°	NULL
cpm	NULL
of	NULL
the	NULL
indi-	NULL
_	NULL
ay	NULL
-L	NULL
Q	NULL
i	NULL
Hikes	NULL
cated	NULL
antisense	NULL
RNA	NULL
probes	NULL
.	NULL

After	NULL
RNAase	NULL
diges-	NULL
ps	NULL
_	NULL
|	NULL
,	NULL
Aucttermse	NULL
cDNA	NULL
.-	NULL
SV40	NULL
Intron	NULL
and	NULL
Ap	NULL
Signal	NULL
tion	NULL
,	NULL
the	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
denaturing	NULL
re	NULL
4-151	NULL
t-polyacrylamide	NULL
gel	NULL
and	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
autora-	NULL
«	NULL
e	NULL
#	NULL
Region	NULL
diographed	NULL
.	NULL

Expected	NULL
sizes	NULL
of	NULL
the	NULL
various	NULL
protected	NULL
Gees	NULL
we	NULL
2	NULL
m	NULL
alue	NULL
fragments	NULL
are	NULL
:	NULL
{	NULL
,	NULL
207	NULL
bases	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
;	NULL
«	NULL
,	NULL
130	NULL
*t	NULL
__	NULL
,	NULL
bases	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
;	NULL
e	NULL
,	NULL
126	NULL
bases	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
;	NULL
=/	NULL
5	NULL
Region	NULL
Ay	NULL
,	NULL
170	NULL
bases	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
;	NULL
,	NULL
205	NULL
bases	NULL
(	NULL
lanes	NULL
5	NULL
«	NULL
a-118	NULL
Enhancers	NULL
and	NULL
10	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Deletion	NULL
constructs	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

we	NULL
.	NULL

Cece	NULL
PB	NULL
so	NULL
The	NULL
various	NULL
deletion	NULL
constructs	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
5	NULL
!	NULL

hss	NULL
%	NULL
flanking	NULL
region	NULL
or	NULL
the	NULL
a-globin	NULL
5	NULL
flanking	NULL
region	NULL
<	NULL
-100	NULL
were	NULL
used	NULL
to	NULL
drive	NULL
luciferase	NULL
expression	NULL
in	NULL
K562	NULL
and	NULL
nsas	NULL
OCIM1	NULL
cells	NULL
.	NULL

The	NULL
indicated	NULL
enhancers	NULL
were	NULL
included	NULL
me	NULL
wiso	NULL
ta	NULL
in	NULL
the	NULL
constructs	NULL
.	NULL

1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
1x89	NULL
and	NULL
antisense	NULL
orientations	NULL
into	NULL
the	NULL
three	NULL
constructs	NULL
with	NULL
the	NULL
different	NULL
unique	NULL
BamHI	NULL
sites	NULL
.	NULL

HS-40	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
unique	NULL
HindIII	NULL
site	NULL
of	NULL
all	NULL
six	NULL
plasmids	NULL
.	NULL

All	NULL
constructs	NULL
were	NULL
sequenced	NULL
around	NULL
the	NULL
site	NULL
of	NULL
end	NULL
fill-in	NULL
reactions	NULL
or	NULL
linker	NULL
additions	NULL
.	NULL

All	NULL
PCR	NULL
products	NULL
were	NULL
sequenced	NULL
com-pletely	NULL
.	NULL

DNA	NULL
sequencing	NULL
was	NULL
performed	NULL
by	NULL
a	NULL
dideoxy	NULL
chain	NULL
termination	NULL
method	NULL
,	NULL
``	NULL
``	NULL
either	NULL
with	NULL
the	NULL
Dye-Deoxy	NULL
kit	NULL
and	NULL
automated	NULL
sequencing	NULL
(	NULL
Applied	NULL
Biosystems	NULL
)	NULL
or	NULL
with	NULL
the	NULL
Sequenase	NULL
kit	NULL
(	NULL
US	NULL
Biochemical	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
purified	NULL
for	NULL
transfection	NULL
by	NULL
the	NULL
alkaline	NULL
lysis	NULL
method	NULL
.	NULL
``	NULL

''	NULL
Plasmid	NULL
DNA	NULL
was	NULL
separated	NULL
from	NULL
bacterial	NULL
genomic	NULL
DNA	NULL
using	NULL
pZ523	NULL
columns	NULL
(	NULL
5'~	NULL
>	NULL
3	NULL
'	NULL
,	NULL
Boulder	NULL
,	NULL
CO	NULL
)	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
.	NULL

-	NULL
Site-directed	NULL
mutants	NULL
were	NULL
made	NULL
by	NULL
a	NULL
two-step	NULL
PCR	NULL
.	NULL

In	NULL
the	NULL
first	NULL
step	NULL
,	NULL
primer	NULL
pairs	NULL
A/B	NULL
and	NULL
C/D	NULL
were	NULL
used	NULL
to	NULL
amplify	NULL
overlapping	NULL
halves	NULL
of	NULL
the	NULL
mutant	NULL
segment	NULL
.	NULL

The	NULL
PCR	NULL
was	NULL
performed	NULL
using	NULL
1	NULL
ng	NULL
of	NULL
C-luciferase	NULL
,	NULL
70	NULL
pmol	NULL
of	NULL
each	NULL
primer	NULL
,	NULL
and	NULL
Pfu	NULL
DNA	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
)	NULL
in	NULL
20	NULL
mmol/L	NULL
TRIS	NULL
pH	NULL
7.5	NULL
,	NULL
8	NULL
mmol/L	NULL
MgCl	NULL
»	NULL
,	NULL
40	NULL
ug/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
200	NULL
pmol/	NULL
L	NULL
each	NULL
deoxyadenosine	NULL
triphosphate	NULL
(	NULL
dATP	NULL
)	NULL
,	NULL
deoxyguanosine	NULL
triphosphate	NULL
(	NULL
dGTP	NULL
)	NULL
,	NULL
deoxycytidine	NULL
triphosphate	NULL
(	NULL
dCTP	NULL
)	NULL
,	NULL
and	NULL
deoxy-thymidine	NULL
triphosphate	NULL
(	NULL
dTTP	NULL
)	NULL
.	NULL

The	NULL
two	NULL
products	NULL
were	NULL
purified	NULL
by	NULL
low	NULL
melting	NULL
point	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
,	NULL
1	NULL
wL	NULL
of	NULL
each	NULL
melted	NULL
gel	NULL
slice	NULL
was	NULL
combined	NULL
,	NULL
and	NULL
the	NULL
full-length	NULL
mutant	NULL
sequence	NULL
was	NULL
amplified	NULL
with	NULL
primer	NULL
pair	NULL
A/D	NULL
.	NULL

The	NULL
resulting	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
Sal	NULL
I	NULL
and	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
wild-type	NULL
enhancerless	NULL
C-luciferase	NULL
construct	NULL
.	NULL

The	NULL
amplified	NULL
segment	NULL
was	NULL
sequenced	NULL
to	NULL
verify	NULL
that	NULL
no	NULL
additional	NULL
mutations	NULL
were	NULL
introduced	NULL
during	NULL
amplification	NULL
.	NULL

For	NULL
both	NULL
the	NULL
-230	NULL
GATA-1	NULL
and	NULL
-240	NULL
CCACC	NULL
mutations	NULL
,	NULL
primer	NULL
A	NULL
was	NULL
5	NULL
``	NULL
-AGCGGATAACAATTTCACACAGG-3	NULL
``	NULL
and	NULL
primer	NULL
D	NULL
was	NULL
5-GCTAATGTCACTGCGAGCG-3	NULL
'	NULL
.	NULL

For	NULL
the	NULL
-230	NULL
GATA-1	NULL
mutation	NULL
,	NULL
primer	NULL
B	NULL
was	NULL
5-CCACAGAGTCTA-GGAGCTCTAGGGGCC-3	NULL
'	NULL
,	NULL
and	NULL
primer	NULL
C	NULL
was	NULL
its	NULL
complement	NULL
.	NULL

For	NULL
the	NULL
-240	NULL
CCACC	NULL
mutation	NULL
,	NULL
primer	NULL
B	NULL
was	NULL
5'-GGGCCC-CAGGATCCCAGGAAGT-3	NULL
'	NULL
and	NULL
primer	NULL
C	NULL
was	NULL
its	NULL
complement	NULL
.	NULL

Mutant	NULL
nucleotides	NULL
are	NULL
underlined	NULL
.	NULL

The	NULL
construct	NULL
with	NULL
both	NULL
the	NULL
-230	NULL
GATA-1	NULL
and	NULL
-240	NULL
CCACC	NULL
mutant	NULL
was	NULL
made	NULL
by	NULL
subjecting	NULL
the	NULL
-230	NULL
GATA-1	NULL
mutant	NULL
construct	NULL
to	NULL
two-step	NULL
PCR	NULL
mutagenesis	NULL
with	NULL
the	NULL
-240	NULL
CCACC	NULL
mutant	NULL
primers	NULL
.	NULL

Electroporation	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
grown	NULL
to	NULL
a	NULL
density	NULL
of	NULL
0.5	NULL
to	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
mL	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
washed	NULL
once	NULL
in	NULL
HEPES-buffered	NULL
saline	NULL
(	NULL
HBS	NULL
;	NULL
20	NULL
mmol/L	NULL
N-2-hydroxyethylpipera-	NULL
zine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
]	NULL
pH	NULL
7.05	NULL
,	NULL
137	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
5	NULL
mmol/L	NULL
KCI	NULL
,	NULL
6	NULL
mmol/L	NULL
glucose	NULL
,	NULL
0.7	NULL
mmol/L	NULL
sodium	NULL
phosphate	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
resuspended	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
mL	NULL
in	NULL
HBS	NULL
,	NULL
and	NULL
0.5	NULL
mL	NULL
of	NULL
cell	NULL
suspension	NULL
was	NULL
added	NULL
to	NULL
a	NULL
standard	NULL
4	NULL
mm	NULL
electroporation	NULL
cuvette	NULL
.	NULL

A	NULL
total	NULL
of	NULL
40	NULL
ug	NULL
of	NULL
DNA	NULL
including	NULL
20	NULL
ug	NULL
of	NULL
test	NULL
plasmid	NULL
(	NULL
luciferase	NULL
construct	NULL
)	NULL
and	NULL
20	NULL
ug	NULL
of	NULL
pRSV-LacZ	NULL
was	NULL
added	NULL
per	NULL
cuvette	NULL
.	NULL

This	NULL
amount	NULL
of	NULL
DNA	NULL
was	NULL
found	NULL
to	NULL
be	NULL
optimal	NULL
for	NULL
transfection	NULL
efficiency	NULL
in	NULL
initial	NULL
experiments	NULL
.	NULL

The	NULL
cell-DNA	NULL
mixture	NULL
was	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

In	NULL
later	NULL
experiments	NULL
,	NULL
the	NULL
plasmid	NULL
pSV-S3Gal	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
instead	NULL
of	NULL
pRSV-LacZ	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
a	NULL
potential	NULL
of	NULL
300	NULL
V	NULL
and	NULL
a	NULL
capacitance	NULL
of	NULL
960	NULL
uF	NULL
using	NULL
a	NULL
GenePulser	NULL
apparatus	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
an	NULL
Electro	NULL
Cell	NULL
Manipulator	NULL
(	NULL
BTX	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
used	NULL
(	NULL
set	NULL
at	NULL
300	NULL
V	NULL
,	NULL
1150	NULL
LF	NULL
,	NULL
and	NULL
720	NULL
)	NULL
.	NULL

The	NULL
time	NULL
constant	NULL
(	NULL
7	NULL
)	NULL
in	NULL
either	NULL
case	NULL
was	NULL
~30	NULL
ms.	NULL
After	NULL
electroporation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
10	NULL
minutes	NULL
on	NULL
ice	NULL
,	NULL
after	NULL
which	NULL
they	NULL
were	NULL
added	NULL
to	NULL
10	NULL
mL	NULL
of	NULL
the	NULL
appropriate	NULL
tissue	NULL
culture	NULL
medium	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
24	NULL
hours	NULL
before	NULL
assaying	NULL
for	NULL
luciferase	NULL
and	NULL
3-galactosidase	NULL
activity	NULL
.	NULL

These	NULL
times	NULL
were	NULL
selected	NULL
based	NULL
on	NULL
the	NULL
time	NULL
at	NULL
which	NULL
luciferase	NULL
activity	NULL
was	NULL
maximal	NULL
as	NULL
determined	NULL
by	NULL
time-course	NULL
experiments	NULL
.	NULL

All	NULL
electroporations	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
,	NULL
and	NULL
each	NULL
experiment	NULL
was	NULL
repeated	NULL
at	NULL
least	NULL
once	NULL
.	NULL

Luciferase	NULL
,	NULL
B-galactosidase	NULL
,	NULL
and	NULL
protein	NULL
assays	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
pelleted	NULL
and	NULL
washed	NULL
with	NULL
1	NULL
mL	NULL
phosphate-buffered	NULL
saline	NULL
.	NULL

The	NULL
washed	NULL
cell	NULL
pellets	NULL
were	NULL
lysed	NULL
in	NULL
200	NULL
gL	NULL
(	NULL
OCIM1	NULL
)	NULL
or	NULL
500	NULL
LL	NULL
(	NULL
K562	NULL
)	NULL
cell	NULL
lysis	NULL
buffer	NULL
(	NULL
100	NULL
mmol/L	NULL
potassium	NULL
phosphate	NULL
pH	NULL
7.8	NULL
,	NULL
6	NULL
mmol/L	NULL
MgSO	NULL
,	NULL
1	NULL
mmol/L	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
0.1	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
Triton	NULL
X-100	NULL
)	NULL
.	NULL

If	NULL
the	NULL
lysates	NULL
were	NULL
not	NULL
used	NULL
immediately	NULL
,	NULL
they	NULL
were	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

Before	NULL
the	NULL
assays	NULL
,	NULL
debris	NULL
was	NULL
cleared	NULL
from	NULL
the	NULL
lysates	NULL
by	NULL
centrifugation	NULL
in	NULL
a	NULL
microcentrifuge	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

For	NULL
the	NULL
luciferase	NULL
assay	NULL
,	NULL
30	NULL
uL	NULL
of	NULL
cleared	NULL
lysate	NULL
was	NULL
added	NULL
to	NULL
350	NULL
uL	NULL
of	NULL
luciferase	NULL
assay	NULL
buffer	NULL
(	NULL
100	NULL
mmol/L	NULL
potassium	NULL
phosphate	NULL
pH	NULL
7.8	NULL
,	NULL
4.4	NULL
mmol/L	NULL
ATP	NULL
,	NULL
6	NULL
mmol/L	NULL
MgSO	NULL
,	NULL
)	NULL
in	NULL
a	NULL
luminometer	NULL
cuvette	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
cuvette	NULL
was	NULL
placed	NULL
in	NULL
a	NULL
luminometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
)	NULL
,	NULL
and	NULL
100	NULL
gL	NULL
of	NULL
0.33	NULL
mg/mL	NULL
luciferin	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
)	NULL
was	NULL
added	NULL
automatically	NULL
.	NULL

Light	NULL
output	NULL
was	NULL
measured	NULL
for	NULL
30	NULL
seconds	NULL
.	NULL

For	NULL
the	NULL
3-galactosidase	NULL
assay	NULL
,	NULL
30	NULL
LL	NULL
of	NULL
cleared	NULL
lysate	NULL
was	NULL
added	NULL
to	NULL
a	NULL
mixture	NULL
of	NULL
200	NULL
gL	NULL
B-galactosidase	NULL
assay	NULL
buffer	NULL
(	NULL
100	NULL
mmol/L	NULL
sodium	NULL
phosphate	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
10	NULL
mmol/L	NULL
KCI	NULL
,	NULL
1	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
54	NULL
mmol/L	NULL
2-mercaptoethanol	NULL
)	NULL
and	NULL
40	NULL
LL	NULL
of	NULL
2	NULL
mg	NULL
per	NULL
mL	NULL
o-nitrophe-nyl-3-p-galactopyranoside	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
in	NULL
a	NULL
96-well	NULL
microtiter	NULL
plate	NULL
.	NULL

The	NULL
assay	NULL
was	NULL
incubated	NULL
at	NULL
37°C	NULL
until	NULL
a	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2590	NULL
yellow	NULL
color	NULL
developed	NULL
,	NULL
40	NULL
of	NULL
1	NULL
mol/L	NULL
NaHCO	NULL
;	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
absorbance	NULL
at	NULL
405	NULL
nm	NULL
was	NULL
measured	NULL
with	NULL
an	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
plate	NULL
reader	NULL
(	NULL
Bio-Tek	NULL
Instruments	NULL
,	NULL
Winooski	NULL
,	NULL
VT	NULL
)	NULL
.	NULL

For	NULL
the	NULL
protein	NULL
assay	NULL
,	NULL
2	NULL
uL	NULL
of	NULL
lysate	NULL
was	NULL
diluted	NULL
in	NULL
198	NULL
wL	NULL
of	NULL
water	NULL
in	NULL
a	NULL
96-well	NULL
microtiter	NULL
plate	NULL
.	NULL

Fifty	NULL
microliters	NULL
of	NULL
Bradford	NULL
protein	NULL
assay*	NULL
``	NULL
reagent	NULL
(	NULL
Bio-Rad	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
absorbance	NULL
at	NULL
570	NULL
nm	NULL
was	NULL
measured	NULL
with	NULL
the	NULL
ELISA	NULL
plate	NULL
reader	NULL
.	NULL

A	NULL
standard	NULL
curve	NULL
was	NULL
constructed	NULL
using	NULL
the	NULL
protein	NULL
standard	NULL
provided	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

The	NULL
assay	NULL
was	NULL
run	NULL
in	NULL
triplicate	NULL
.	NULL

RNAase	NULL
protection	NULL
.	NULL

-	NULL
RNA	NULL
isolation	NULL
,	NULL
generation	NULL
of	NULL
radiolabeled	NULL
probes	NULL
,	NULL
and	NULL
RNAase	NULL
protections	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
was	NULL
hybridized	NULL
to	NULL
1	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
radiolabeled	NULL
antisense	NULL
RNA	NULL
for	NULL
each	NULL
assay	NULL
.	NULL

The	NULL
following	NULL
plasmids	NULL
were	NULL
used	NULL
for	NULL
generation	NULL
of	NULL
RNA	NULL
probes	NULL
:	NULL
human	NULL
£	NULL
,	NULL
pT7hC207	NULL
,	NULL
``	NULL
human	NULL
a	NULL
,	NULL
pSP6ha130	NULL
(	NULL
a	NULL
gift	NULL
of	NULL
S.	NULL
Liebhaber	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
,	NULL
Philadelphia	NULL
)	NULL
,	NULL
human	NULL
e	NULL
,	NULL
pSP6he126	NULL
,	NULL
``	NULL
°	NULL
human	NULL
*y	NULL
,	NULL
pT7h*y	NULL
``	NULL
170	NULL
,	NULL
``	NULL
°	NULL
and	NULL
human	NULL
3	NULL
,	NULL
pT7h	NULL
$	NULL
``	NULL
205	NULL
.	NULL
``	NULL

'	NULL
The	NULL
RNA	NULL
polymerase	NULL
used	NULL
for	NULL
each	NULL
plasmid	NULL
is	NULL
indicated	NULL
in	NULL
the	NULL
name	NULL
of	NULL
the	NULL
plasmid	NULL
,	NULL
as	NULL
is	NULL
the	NULL
size	NULL
of	NULL
the	NULL
protected	NULL
fragment	NULL
.	NULL

Primer	NULL
extension	NULL
.	NULL

-	NULL
Ten	NULL
picomoles	NULL
of	NULL
an	NULL
oligonucleotide	NULL
primer	NULL
specific	NULL
for	NULL
luciferase	NULL
RNA	NULL
(	NULL
5-GCTAATGTCACTGCGAGCG-3	NULL
'	NULL
)	NULL
was	NULL
end	NULL
labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
50	NULL
mmol/L	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mmol/L	NULL
MgCl	NULL
,	NULL
,	NULL
5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
0.1	NULL
mmol/L	NULL
spermidine	NULL
,	NULL
and	NULL
30	NULL
Ci	NULL
[	NULL
8	NULL
°PJATP	NULL
(	NULL
3,000	NULL
Ci	NULL
per	NULL
mmol	NULL
,	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
10	NULL
L	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
labeling	NULL
reaction	NULL
was	NULL
diluted	NULL
to	NULL
100	NULL
uL	NULL
,	NULL
and	NULL
1	NULL
gL	NULL
of	NULL
the	NULL
diluted	NULL
oligonucleotide	NULL
was	NULL
mixed	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
11	NULL
L	NULL
of	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
buffer	NULL
(	NULL
50	NULL
mmol/L	NULL
TRIS-HCI	NULL
pH	NULL
8.3	NULL
,	NULL
50	NULL
mmol/L	NULL
KCI	NULL
,	NULL
10	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
,	NULL
10	NULL
mmol/L	NULL
DTT	NULL
,	NULL
1	NULL
mmol/L	NULL
each	NULL
dATP	NULL
,	NULL
dCTP	NULL
,	NULL
dGTP	NULL
,	NULL
and	NULL
dTTP	NULL
,	NULL
and	NULL
0.5	NULL
mmol/L	NULL
spermidine	NULL
)	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
heated	NULL
to	NULL
58°C	NULL
for	NULL
30	NULL
minutes	NULL
then	NULL
slowly	NULL
cooled	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

cDNA	NULL
was	NULL
synthesized	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
AMV	NULL
RT	NULL
buffer	NULL
with	NULL
2.8	NULL
mmol/L	NULL
sodium	NULL
pyrophosphate	NULL
and	NULL
1	NULL
U	NULL
of	NULL
AMV	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Promega	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
42°C	NULL
.	NULL

Twenty	NULL
microliters	NULL
of	NULL
loading	NULL
dye	NULL
(	NULL
98	NULL
%	NULL
deionized	NULL
formamide	NULL
,	NULL
10	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
[	NULL
wt/vol	NULL
]	NULL
xylene	NULL
cyanol	NULL
,	NULL
0.1	NULL
%	NULL
[	NULL
wt/vol	NULL
]	NULL
bromo-phenol	NULL
blue	NULL
)	NULL
was	NULL
added	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
heated	NULL
to	NULL
90°C	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
20	NULL
gL	NULL
of	NULL
the	NULL
sample	NULL
was	NULL
used	NULL
for	NULL
electrophoresis	NULL
.	NULL

The	NULL
primer	NULL
extension	NULL
products	NULL
were	NULL
electrophoresed	NULL
through	NULL
a	NULL
5	NULL
%	NULL
(	NULL
wt/	NULL
vol	NULL
)	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
containing	NULL
50	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
urea	NULL
and	NULL
1x	NULL
TBE	NULL
(	NULL
89	NULL
mmol/L	NULL
TRIS	NULL
base	NULL
,	NULL
89	NULL
mmol/L	NULL
boric	NULL
acid	NULL
,	NULL
2	NULL
mmol/	NULL
L	NULL
EDTA	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

-	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
K562	NULL
and	NULL
OCIM1	NULL
cells	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL
``	NULL

Recombinant	NULL
GST/GATA-1	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
D.LK	NULL
.	NULL

Martin	NULL
(	NULL
Fred	NULL
Hutchinson	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Recombinant	NULL
GST/EKLF®	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
J.	NULL
Bieker	NULL
(	NULL
Mount	NULL
Sinai	NULL
Medical	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Recombinant	NULL
Spl	NULL
was	NULL
obtained	NULL
from	NULL
Promega	NULL
.	NULL

Double-stranded	NULL
probe	NULL
and	NULL
competitor	NULL
DNA	NULL
were	NULL
synthesized	NULL
by	NULL
using	NULL
a	NULL
short	NULL
oligonucleotide	NULL
to	NULL
prime	NULL
synthesis	NULL
of	NULL
second-strand	NULL
DNA	NULL
using	NULL
a	NULL
longer	NULL
oligonucleotide	NULL
template	NULL
.	NULL

For	NULL
radiolabeled	NULL
probes	NULL
,	NULL
100	NULL
pmol	NULL
of	NULL
primer	NULL
was	NULL
annealed	NULL
to	NULL
4	NULL
pmol	NULL
of	NULL
template	NULL
.	NULL

Second-strand	NULL
DNA	NULL
was	NULL
synthesized	NULL
using	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
50	NULL
mmol/L	NULL
TRIS	NULL
pH	NULL
8.0	NULL
,	NULL
50	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
5	NULL
mmo/L	NULL
MgCl	NULL
,	NULL
,	NULL
200	NULL
pmol/L	NULL
each	NULL
dATP	NULL
,	NULL
dGTP	NULL
,	NULL
and	NULL
dTTP	NULL
,	NULL
and	NULL
50	NULL
£Ci	NULL
{	NULL
a	NULL
``	NULL
°P	NULL
]	NULL
dCTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
,	NULL
DuPont/New	NULL
England	NULL
Nuclear	NULL
[	NULL
NEN	NULL
]	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
at	NULL
16°C	NULL
for	NULL
2	NULL
hours	NULL
.	NULL

200	NULL
umol/L	NULL
dCTP	NULL
was	NULL
added	NULL
for	NULL
the	NULL
last	NULL
20	NULL
minutes	NULL
of	NULL
incubation	NULL
to	NULL
complete	NULL
synthesis	NULL
of	NULL
any	NULL
partially	NULL
completed	NULL
second	NULL
strands	NULL
.	NULL

Nonradioactive	NULL
competitor	NULL
DNA	NULL
was	NULL
synthesized	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
,	NULL
except	NULL
200	NULL
gmol/L	NULL
dCTP	NULL
was	NULL
substituted	NULL
for	NULL
the	NULL
radionuclide	NULL
.	NULL

Radiolabeled	NULL
DNA	NULL
was	NULL
purified	NULL
SABATH	NULL
ET	NULL
AL	NULL
by	NULL
spun	NULL
column	NULL
chromatography	NULL
through	NULL
Sephadex	NULL
G-25	NULL
columns	NULL
(	NULL
select	NULL
columns	NULL
,	NULL
53	NULL
``	NULL
)	NULL
.	NULL

The	NULL
3	NULL
'	NULL
enhancer	NULL
oligonucleotide	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
DLK	NULL
.	NULL

Martin	NULL
and	NULL
was	NULL
supplied	NULL
as	NULL
double-stranded	NULL
DNA	NULL
.	NULL

It	NULL
was	NULL
end	NULL
labeled	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
and	NULL
[	NULL
8	NULL
P	NULL
]	NULL
-ATP	NULL
(	NULL
6,000	NULL
Ci/mmol	NULL
,	NULL
DuPont/NEN	NULL
)	NULL
and	NULL
purified	NULL
by	NULL
spun	NULL
column	NULL
chromatography	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
by	NULL
incubating	NULL
~5	NULL
pg	NULL
of	NULL
crude	NULL
nuclear	NULL
extract	NULL
or	NULL
40	NULL
ng	NULL
of	NULL
GST/GATA-1	NULL
was	NULL
incubated	NULL
with	NULL
3	NULL
x	NULL
10°	NULL
cpm	NULL
of	NULL
radiolabeled	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
pH	NULL
7.9	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.5	NULL
mmol/L	NULL
DTT	NULL
,	NULL
100	NULL
mmol/L	NULL
NaCl	NULL
;	NULL
,	NULL
I	NULL
mmol/L	NULL
1.2	NULL
mmol/L	NULL
ZnCl	NULL
,	NULL
12	NULL
%	NULL
glycerol	NULL
,	NULL
0.3	NULL
mg	NULL
per	NULL
mL	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
:	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
3	NULL
mmol/L	NULL
nonspecific	NULL
single-stranded	NULL
oligonucleotide	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Nonspecific	NULL
competitor	NULL
DNA	NULL
was	NULL
omitted	NULL
when	NULL
recombinant	NULL
GST/	NULL
GATA-I1	NULL
was	NULL
used	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
with	NULL
competitor	NULL
DNA	NULL
for	NULL
10	NULL
minutes	NULL
on	NULL
ice	NULL
before	NULL
radiolabeled	NULL
probe	NULL
was	NULL
added	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
containing	NULL
50	NULL
mmol/L	NULL
TRIS	NULL
pH	NULL
8.3	NULL
,	NULL
400	NULL
mmol/L	NULL
glycine	NULL
,	NULL
and	NULL
2	NULL
mmol/L	NULL
EDTA	NULL
that	NULL
had	NULL
been	NULL
pre-electrophoresed	NULL
at	NULL
100	NULL
V	NULL
for	NULL
90	NULL
minutes	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
run	NULL
at	NULL
35	NULL
mA	NULL
constant	NULL
current	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
autoradiographed	NULL
.	NULL

The	NULL
following	NULL
oligonucleotide	NULL
template/primer	NULL
pairs	NULL
were	NULL
used	NULL
(	NULL
mutant	NULL
sequences	NULL
are	NULL
underlined	NULL
)	NULL
:	NULL
-230	NULL
GATA-1	NULL
,	NULL
5-TCTAGGAGAGATAGGGGCCCCA-3/5	NULL
``	NULL
-TGGGGC-3	NULL
'	NULL
;	NULL
-230	NULL
mutant	NULL
GATA-1	NULL
,	NULL
5	NULL
``	NULL
-TCTAGGAGCTCGAGGGGCCCCA-3'/	NULL
5-TGGGGC-3	NULL
'	NULL
;	NULL
-240	NULL
CCACC	NULL
,	NULL
5-GGGCCCCaACCcCcTCcccaGG-AAGT-3'/5	NULL
``	NULL
-ACTTCCTG-3	NULL
'	NULL
;	NULL
-240	NULL
mutant	NULL
CCACC	NULL
,	NULL
5-GGGCC-CCAGGATCCCAGGAAGT-3'/5*-ACTTCCTG-3	NULL
'	NULL
;	NULL
&	NULL
(	NULL
-123/-84	NULL
)	NULL
,	NULL
5-CCTTTGTCACTGGATCTGATAATGAAACACCACCCC	NULL
TGCAG-3	NULL
``	NULL
/5	NULL
``	NULL
-CTGCAGG-3	NULL
'	NULL
;	NULL
$	NULL
A-globin	NULL
3	NULL
'	NULL
enhancer	NULL
(	NULL
double-stranded	NULL
)	NULL
,	NULL
TTCTGG-3	NULL
'	NULL
.	NULL

RESULTS	NULL
Cells	NULL
and	NULL
constructs	NULL
used	NULL
for	NULL
transient	NULL
transfection	NULL
.	NULL

-	NULL
One	NULL
goal	NULL
of	NULL
these	NULL
studies	NULL
was	NULL
to	NULL
use	NULL
transient	NULL
transfection	NULL
to	NULL
compare	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
promoters	NULL
in	NULL
erythroid	NULL
cell	NULL
lines	NULL
that	NULL
do	NULL
or	NULL
do	NULL
not	NULL
express	NULL
their	NULL
endogenous	NULL
E-globin	NULL
gene	NULL
.	NULL

Two	NULL
cell	NULL
lines	NULL
,	NULL
K562	NULL
,	NULL
which	NULL
expresses	NULL
G-globin	NULL
,	NULL
and	NULL
OCIM1	NULL
,	NULL
which	NULL
does	NULL
not	NULL
,	NULL
were	NULL
selected	NULL
for	NULL
this	NULL
analysis	NULL
.	NULL

To	NULL
verify	NULL
the	NULL
phenotype	NULL
of	NULL
each	NULL
cell	NULL
line	NULL
,	NULL
an	NULL
RNAase	NULL
protection	NULL
experiment	NULL
was	NULL
performed	NULL
using	NULL
antisense	NULL
RNA	NULL
probes	NULL
for	NULL
the	NULL
various	NULL
human	NULL
globins	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
1A	NULL
,	NULL
K562	NULL
cells	NULL
express	NULL
C-	NULL
,	NULL
a-	NULL
,	NULL
and	NULL
6-globin	NULL
RNA	NULL
.	NULL

The	NULL
K562	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
an	NULL
uninduced	NULL
state	NULL
;	NULL
hemin	NULL
induction	NULL
resulted	NULL
in	NULL
a	NULL
twofold	NULL
increase	NULL
in	NULL
{	NULL
-globin	NULL
RNA	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

No	NULL
e-	NULL
or	NULL
B-globin	NULL
RNA	NULL
was	NULL
detected	NULL
in	NULL
these	NULL
K562	NULL
cells	NULL
.	NULL

Other	NULL
clones	NULL
of	NULL
K562	NULL
cells	NULL
are	NULL
known	NULL
to	NULL
express	NULL
e-globin	NULL
,	NULL
especially	NULL
when	NULL
induced	NULL
with	NULL
hemin	NULL
.	NULL
'	NULL

''	NULL
*'*	NULL
The	NULL
lack	NULL
of	NULL
e	NULL
expression	NULL
in	NULL
this	NULL
case	NULL
may	NULL
be	NULL
a	NULL
unique	NULL
property	NULL
of	NULL
the	NULL
specific	NULL
K562	NULL
cells	NULL
used	NULL
,	NULL
or	NULL
a	NULL
result	NULL
of	NULL
not	NULL
inducing	NULL
the	NULL
K562	NULL
cells	NULL
.	NULL

OCIM1	NULL
cells	NULL
express	NULL
only	NULL
a-	NULL
and	NULL
y-globin	NULL
RNA	NULL
;	NULL
no	NULL
-globin	NULL
RNA	NULL
was	NULL
detected	NULL
even	NULL
after	NULL
long	NULL
exposures	NULL
of	NULL
the	NULL
RNAase	NULL
protection	NULL
gel	NULL
,	NULL
nor	NULL
was	NULL
any	NULL
e-	NULL
or	NULL
-globin	NULL
RNA	NULL
detected	NULL
.	NULL

A	NULL
series	NULL
of	NULL
{	NULL
-globin	NULL
promoter	NULL
deletion	NULL
constructs	NULL
was	NULL
used	NULL
to	NULL
drive	NULL
expression	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

The	NULL
5	NULL
``	NULL
ends	NULL
of	NULL
the	NULL
various	NULL
deletions	NULL
were	NULL
located	NULL
557	NULL
,	NULL
417	NULL
,	NULL
207	NULL
,	NULL
or	NULL
128	NULL
bp	NULL
5	NULL
'	NULL
to	NULL
the	NULL
&	NULL
-globin	NULL
mRNA	NULL
cap	NULL
site	NULL
.	NULL
``	NULL

These	NULL
are	NULL
the	NULL
same	NULL
deletions	NULL
used	NULL
previously	NULL
in	NULL
transgenic	NULL
mouse	NULL
experiments	NULL
.	NULL
``	NULL

The	NULL
various	NULL
{	NULL
-globin	NULL
promoters	NULL
were	NULL
used	NULL
in	NULL
association	NULL
with	NULL
four	NULL
different	NULL
enhancers	NULL
:	NULL
wLCR	NULL
,	NULL
a	NULL
construct	NULL
containing	NULL
hypersensitive	NULL
sites	NULL
1	NULL
through	NULL
4	NULL
of	NULL
the	NULL
BA-globin	NULL
LCR*	NULL
;	NULL
HS2	NULL
,	NULL
hypersensitive	NULL
site	NULL
2	NULL
of	NULL
the	NULL
LCR	NULL
;	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

C-GLOBIN	NULL
UPSTREAM	NULL
REGULATORY	NULL
ELEMENT	NULL
HS-40	NULL
,	NULL
a	NULL
1.4-kbp	NULL
fragment	NULL
containing	NULL
the	NULL
-globin	NULL
locus	NULL
upstream	NULL
enhancer	NULL
``	NULL
;	NULL
or	NULL
a	NULL
307-bp	NULL
PCR	NULL
product	NULL
containing	NULL
the	NULL
core	NULL
HS-40	NULL
enhancer	NULL
.	NULL
``	NULL

The	NULL
various	NULL
promoter	NULL
constructs	NULL
were	NULL
used	NULL
without	NULL
enhancers	NULL
as	NULL
well	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
K562	NULL
and	NULL
OCIM	NULL
1	NULL
cells	NULL
by	NULL
electroporation	NULL
along	NULL
with	NULL
a	NULL
3-galactosidase	NULL
expression	NULL
plasmid	NULL
that	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

To	NULL
compare	NULL
relative	NULL
enhancer	NULL
activities	NULL
,	NULL
the	NULL
x-luciferase	NULL
constructs	NULL
,	NULL
the	NULL
constructs	NULL
,	NULL
and	NULL
pRSV-Luc	NULL
were	NULL
transfected	NULL
into	NULL
K562	NULL
cells	NULL
;	NULL
the	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
the	NULL
a-	NULL
and	NULL
C-globin	NULL
promoters	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
RSV	NULL
LTR	NULL
``	NULL
promoter	NULL
's	NULL
activity	NULL
.	NULL

Hypersensitive	NULL
site	NULL
2	NULL
of	NULL
the	NULL
-globin	NULL
LCR	NULL
produced	NULL
the	NULL
highest	NULL
levels	NULL
of	NULL
a-globin	NULL
promoter	NULL
activity	NULL
(	NULL
188	NULL
%	NULL
of	NULL
RSV	NULL
activity	NULL
)	NULL
,	NULL
although	NULL
the	NULL
uHS-40	NULL
enhancer	NULL
was	NULL
nearly	NULL
as	NULL
effective	NULL
(	NULL
179	NULL
%	NULL
of	NULL
RSV	NULL
)	NULL
.	NULL

The	NULL
a-globin	NULL
promoter	NULL
was	NULL
less	NULL
active	NULL
when	NULL
coupled	NULL
to	NULL
HS-40	NULL
or	NULL
uLCR	NULL
(	NULL
87	NULL
%	NULL
and	NULL
58	NULL
%	NULL
of	NULL
RSV	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
uHS-40	NULL
construct	NULL
was	NULL
most	NULL
effective	NULL
at	NULL
driving	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
(	NULL
79	NULL
%	NULL
of	NULL
RSV	NULL
)	NULL
.	NULL

Less	NULL
luciferase	NULL
activity	NULL
was	NULL
produced	NULL
from	NULL
the	NULL
E-globin	NULL
promoter	NULL
coupled	NULL
to	NULL
HS-40	NULL
or	NULL
HS	NULL
$	NULL
2	NULL
(	NULL
31	NULL
%	NULL
and	NULL
34	NULL
%	NULL
of	NULL
RSV	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

As	NULL
with	NULL
the	NULL
-globin	NULL
promoter	NULL
,	NULL
the	NULL
LCR	NULL
enhancer	NULL
was	NULL
the	NULL
least	NULL
active	NULL
of	NULL
the	NULL
enhancers	NULL
tested	NULL
in	NULL
driving	NULL
the	NULL
«	NULL
-and	NULL
&	NULL
-globin	NULL
promoter	NULL
(	NULL
9	NULL
%	NULL
of	NULL
RSV	NULL
)	NULL
.	NULL

Very	NULL
little	NULL
luciferase	NULL
activity	NULL
was	NULL
produced	NULL
by	NULL
the	NULL
constructs	NULL
lacking	NULL
enhancers	NULL
(	NULL
0.4	NULL
%	NULL
and	NULL
0.3	NULL
%	NULL
of	NULL
RSV	NULL
for	NULL
a	NULL
and	NULL
G	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
although	NULL
the	NULL
luciferase	NULL
activity	NULL
observed	NULL
was	NULL
still	NULL
fivefold	NULL
higher	NULL
than	NULL
background	NULL
.	NULL

A	NULL
positive	NULL
regulatory	NULL
element	NULL
is	NULL
located	NULL
between	NULL
417	NULL
and	NULL
207	NULL
bp	NULL
upstream	NULL
from	NULL
the	NULL
-globin	NULL
promoter	NULL
.	NULL

-	NULL
To	NULL
determine	NULL
whether	NULL
any	NULL
positive	NULL
or	NULL
negative	NULL
regulatory	NULL
elements	NULL
are	NULL
present	NULL
in	NULL
the	NULL
{	NULL
-globin	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
,	NULL
a	NULL
series	NULL
of	NULL
C-globin	NULL
5	NULL
'	NULL
truncation	NULL
mutants	NULL
were	NULL
linked	NULL
to	NULL
luciferase	NULL
in	NULL
constructs	NULL
containing	NULL
the	NULL
various	NULL
enhancers	NULL
.	NULL

Luciferase	NULL
ac	NULL
200	NULL
3	NULL
€	NULL
>	NULL
@	NULL
§	NULL
1s0	NULL
}	NULL
-4	NULL
FB	NULL
§	NULL
100	NULL
}	NULL
$	NULL
a	NULL
>	NULL
a	NULL
$	NULL
2	NULL
w	NULL
)	NULL
B	NULL
©	NULL
3	NULL
%	NULL
°	NULL
No	NULL
uLcR	NULL
ns	NULL
n5-40	NULL
__	NULL
Enhancer	NULL
Fig	NULL
2	NULL
.	NULL

Comparison	NULL
of	NULL
enhancer	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
various	NULL
enhancers	NULL
were	NULL
inserted	NULL
into	NULL
plasmids	NULL
in	NULL
which	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
was	NULL
under	NULL
control	NULL
of	NULL
the	NULL
-globin	NULL
(	NULL
#	NULL
)	NULL
or	NULL
{	NULL
-globin	NULL
promoter	NULL
(	NULL
C	NULL
)	NULL
,	NULL
see	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

The	NULL
{	NULL
-globin	NULL
promoter	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
included	NULL
the	NULL
full	NULL
557	NULL
bp	NULL
of	NULL
5	NULL
flanking	NULL
sequence	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
these	NULL
promoters	NULL
were	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
RSV	NULL
LTR	NULL
promoter	NULL
.	NULL

Twenty	NULL
micrograms	NULL
of	NULL
the	NULL
various	NULL
luciferase	NULL
expression	NULL
plasmids	NULL
were	NULL
cotransfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
pRSV-LacZ	NULL
into	NULL
10°	NULL
K562	NULL
cells	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
0.5	NULL
mL	NULL
.	NULL

After	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
at	NULL
which	NULL
time	NULL
assays	NULL
for	NULL
total	NULL
protein	NULL
,	NULL
B-galactosidase	NULL
,	NULL
and	NULL
luciferase	NULL
were	NULL
performed	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
to	NULL
-galactosidase	NULL
activity	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
the	NULL
constructs	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
pRSV-Luc	NULL
,	NULL
defined	NULL
as	NULL
100	NULL
%	NULL
activity	NULL
.	NULL

2591	NULL
A	NULL
B	NULL
800	NULL
400	NULL
el	NULL
HS2	NULL
£5	NULL
me	NULL
}	NULL
[	NULL
]	NULL
wes	NULL
|	NULL
1	NULL
$	NULL
i	NULL
1	NULL
1	NULL
sok	NULL
's	NULL
i	NULL
8	NULL
5	NULL
*	NULL
7	NULL
%	NULL
#	NULL
Es	NULL
100	NULL
F	NULL
4	NULL
100	NULL
,	NULL
a	NULL
E	NULL
9	NULL
o	NULL
o.	NULL
ig	NULL
d	NULL
«	NULL
$	NULL
$	NULL
w	NULL
}	NULL
|	NULL
``	NULL
I	NULL
ET	NULL
)	NULL
&	NULL
6	NULL
m_m	NULL
5	NULL
I	NULL
``	NULL
!	NULL

b	NULL
n	NULL
i	NULL
o	NULL
t	NULL
hoa	NULL
A	NULL
?	NULL

?	NULL

?	NULL

fr	NULL
fr	NULL
,	NULL
>	NULL
3	NULL
&	NULL
%	NULL
C	NULL
D	NULL
=	NULL
tso	NULL
I	NULL
Hs-40	NULL
|	NULL
150	NULL
f	NULL
wHS-40	NULL
4	NULL
s	NULL
=	NULL
<	NULL
e	NULL
&	NULL
g	NULL
;	NULL
La	NULL
T	NULL
3	NULL
5	NULL
§	NULL
&	NULL
§	NULL
§	NULL
100	NULL
}	NULL
4	NULL
100	NULL
)	NULL
*	NULL
3	NULL
5	NULL
g	NULL
‘	NULL
la	NULL
§§	NULL
sof	NULL
{	NULL
j	NULL
``	NULL
PF	NULL
7	NULL
=	NULL
is	NULL
$	NULL
%	NULL
o	NULL
'~	NULL
*~	NULL
a	NULL
.	NULL
``	NULL

g	NULL
rt	NULL
”	NULL
?	NULL

'~	NULL
/	NULL
a	NULL
,	NULL
.	NULL

5	NULL
DE	NULL
]	NULL
b	NULL
Any	NULL
*y	NULL
Tr	NULL
,	NULL
Sp	NULL
Tn	NULL
Io	NULL
,	NULL
To	NULL
,	NULL
To	NULL
.	NULL

y	NULL
43	NULL
>	NULL
b	NULL
3	NULL
34	NULL
*3	NULL
G	NULL
%	NULL
E	NULL
F	NULL
,	NULL
3	NULL
s0000	NULL
}	NULL
No	NULL
Enhancer	NULL
]	NULL
-	NULL
°°	NULL
[	NULL
l	NULL
HS-40	NULL
8	NULL
z	NULL
f	NULL
ff	NULL
a	NULL
3	NULL
§	NULL
a	NULL
2	NULL
5	NULL
3°	NULL
G	NULL
§	NULL
§	NULL
100	NULL
}	NULL
4	NULL
100f	NULL
l	NULL
B	NULL
@	NULL
E	NULL
G	NULL
o	NULL
§	NULL
&	NULL
SE	NULL
,	NULL
so	NULL
F	NULL
4	NULL
50	NULL
F	NULL
h	NULL
§	NULL
&	NULL
33	NULL
o	NULL
£	NULL
ale	NULL
o	NULL
mf	NULL
i	NULL
Fa	NULL
74	NULL
4s	NULL
F	NULL
b	NULL
an	NULL
J	NULL
.	NULL

5	NULL
L	NULL
4s	NULL
a	NULL
,	NULL
As	NULL
,	NULL
A	NULL
+o	NULL
``	NULL
A	NULL
&	NULL
*	NULL
,	NULL
``	NULL
x	NULL
Le	NULL
s	NULL
&	NULL
&	NULL
he	NULL
&	NULL
%	NULL
>	NULL
``	NULL
3	NULL
.	NULL

*	NULL
%	NULL
&	NULL
Fig	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
deletions	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
on	NULL
promoter	NULL
function	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

K562	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
luciferase	NULL
constructs	NULL
containing	NULL
successive	NULL
deletions	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
driving	NULL
luciferase	NULL
expression	NULL
.	NULL

The	NULL
various	NULL
enhancers	NULL
used	NULL
in	NULL
Fig	NULL
2	NULL
were	NULL
inserted	NULL
into	NULL
these	NULL
constructs	NULL
.	NULL

Transfections	NULL
and	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
the	NULL
constructs	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
{	NULL
(	NULL
-557	NULL
)	NULL
construct	NULL
used	NULL
for	NULL
each	NULL
experiment	NULL
,	NULL
defined	NULL
as	NULL
100	NULL
%	NULL
activity	NULL
.	NULL

Activity	NULL
of	NULL
RSV-Luc	NULL
is	NULL
shown	NULL
for	NULL
comparison	NULL
.	NULL

The	NULL
various	NULL
enhancers	NULL
used	NULL
included	NULL
LCR	NULL
(	NULL
A	NULL
)	NULL
,	NULL
HS2	NULL
(	NULL
B	NULL
)	NULL
,	NULL
HS-40	NULL
(	NULL
C	NULL
)	NULL
,	NULL
40	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Constructs	NULL
lacking	NULL
enhancers	NULL
were	NULL
transfected	NULL
as	NULL
well	NULL
(	NULL
E	NULL
)	NULL
.	NULL

F	NULL
shows	NULL
the	NULL
result	NULL
of	NULL
an	NULL
internal	NULL
deletion	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
from	NULL
-417	NULL
to	NULL
-207	NULL
compared	NULL
with	NULL
the	NULL
{	NULL
(	NULL
-557	NULL
)	NULL
-	NULL
and	NULL
{	NULL
(	NULL
-128	NULL
)	NULL
-luciferase	NULL
constructs	NULL
,	NULL
using	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

tivity	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
activity	NULL
of	NULL
a	NULL
full-length	NULL
E-globin	NULL
promoter	NULL
(	NULL
containing	NULL
557	NULL
bp	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
)	NULL
.	NULL

Comparable	NULL
amounts	NULL
of	NULL
luciferase	NULL
activity	NULL
were	NULL
produced	NULL
from	NULL
promoters	NULL
containing	NULL
557	NULL
or	NULL
417	NULL
bp	NULL
of	NULL
5	NULL
flanking	NULL
sequence	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
enhancer	NULL
used	NULL
,	NULL
if	NULL
any	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
A	NULL
through	NULL
E	NULL
)	NULL
.	NULL

When	NULL
sequences	NULL
from	NULL
-417	NULL
to	NULL
-207	NULL
were	NULL
deleted	NULL
,	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
luciferase	NULL
activity	NULL
was	NULL
seen	NULL
.	NULL

The	NULL
loss	NULL
in	NULL
promoter	NULL
activity	NULL
was	NULL
seen	NULL
with	NULL
all	NULL
enhancers	NULL
,	NULL
but	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
decrease	NULL
depended	NULL
on	NULL
the	NULL
enhancer	NULL
present	NULL
in	NULL
the	NULL
construct	NULL
.	NULL

With	NULL
the	NULL
LCR	NULL
and	NULL
HS-40	NULL
en-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2592	NULL
>	NULL
&	NULL
pLCR	NULL
a	NULL
8	NULL
r	NULL
R	NULL
Luciferase/f-Galactosidase	NULL
(	NULL
%	NULL
of	NULL
a-globin	NULL
promoter	NULL
activity	NULL
)	NULL
e	NULL
B	NULL
&	NULL
8	NULL
8	NULL
8	NULL
U	NULL
I-1	NULL
1	NULL
|	NULL
e	NULL
4	NULL
s	NULL
s	NULL
s	NULL
&	NULL
[	NULL
88	NULL
%	NULL
``	NULL
&	NULL
13	NULL
#	NULL
#	NULL
0	NULL
t	NULL
C	NULL
D	NULL
g	NULL
soo	NULL
HS-40	NULL
xo	NULL
wHS-40	NULL
g	NULL
?	NULL

400k	NULL
J	NULL
;	NULL
l	NULL
a	NULL
Pj	NULL
J	NULL
;	NULL
#	NULL
§§	NULL
100	NULL
F	NULL
4	NULL
100¢	NULL
``	NULL
g	NULL
g	NULL
so	NULL
F	NULL
4	NULL
80	NULL
f	NULL
7	NULL
&	NULL
io=|	NULL
|	NULL
=	NULL
'	NULL
g	NULL
$	NULL
``	NULL
}	NULL
4	NULL
«	NULL
}	NULL
4	NULL
6	NULL
20	NULL
b	NULL
4	NULL
20	NULL
f	NULL
h	NULL
7	NULL
£	NULL
o	NULL
I	NULL
‘	NULL
I	NULL
n	NULL
m	NULL
o	NULL
%	NULL
ﬂ	NULL
n	NULL
[	NULL
``	NULL
I	NULL
n	NULL
h	NULL
*	NULL
Tan	NULL
Fu	NULL
73	NULL
,	NULL
4	NULL
°	NULL
L	NULL
K	NULL
,	NULL
Ho	NULL
6	NULL
*	NULL
5	NULL
3	NULL
p	NULL
3	NULL
``	NULL
o	NULL
$	NULL
>	NULL
3	NULL
%	NULL
E	NULL
F	NULL
mE	NULL
[	NULL
l	NULL
No	NULL
Enhlnelr	NULL
``	NULL
mg	NULL
``	NULL
5-402	NULL
:	NULL
(	NULL
%	NULL
of	NULL
-globin	NULL
promoter	NULL
activity	NULL
)	NULL
s	NULL
s	NULL
s	NULL
&	NULL
}	NULL
e	NULL
B	NULL
&	NULL
8	NULL
s	NULL
§	NULL
CCO	NULL
a	NULL
}	NULL
20	NULL
t	NULL
{	NULL
o	NULL
Cm	NULL
_	NULL
``	NULL
s	NULL
5	NULL
_c	NULL
b	NULL
t	NULL
Fe	NULL
Fy	NULL
Lz	NULL
,	NULL
4	NULL
m	NULL
t	NULL
4	NULL
,	NULL
4	NULL
%	NULL
*	NULL
*	NULL
-	NULL
$	NULL
3	NULL
%	NULL
%	NULL
``	NULL
o	NULL
5	NULL
3	NULL
%	NULL
,	NULL
%	NULL
*	NULL
%	NULL
Fig	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
deletions	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
5°	NULL
flanking	NULL
region	NULL
on	NULL
promoter	NULL
function	NULL
in	NULL
OCIM1	NULL
cells	NULL
.	NULL

OCIM1	NULL
cells	NULL
were	NULL
transfected	NULL
and	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
for	NULL
the	NULL
K562	NULL
cells	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
2	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
OCIM1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
RSV	NULL
and	NULL
a-globin	NULL
constructs	NULL
as	NULL
well	NULL
as	NULL
the	NULL
{	NULL
-globin	NULL
deletion	NULL
constructs	NULL
.	NULL

The	NULL
enhancers	NULL
used	NULL
are	NULL
the	NULL
same	NULL
as	NULL
in	NULL
Fig	NULL
3	NULL
.	NULL

The	NULL
activities	NULL
of	NULL
the	NULL
constructs	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
corresponding	NULL
-globin	NULL
promoter	NULL
construct	NULL
,	NULL
defined	NULL
as	NULL
100	NULL
%	NULL
activity	NULL
.	NULL

(	NULL
F	NULL
)	NULL
shows	NULL
the	NULL
result	NULL
of	NULL
an	NULL
internal	NULL
deletion	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
from	NULL
-417	NULL
to	NULL
-207	NULL
compared	NULL
with	NULL
the	NULL
{	NULL
(	NULL
-557	NULL
)	NULL
-	NULL
,	NULL
{	NULL
(	NULL
-128	NULL
)	NULL
-	NULL
,	NULL
and	NULL
a-luciferase	NULL
constructs	NULL
,	NULL
all	NULL
using	NULL
the	NULL
HS-40	NULL
enhancer	NULL
.	NULL

hancers	NULL
,	NULL
the	NULL
promoters	NULL
containing	NULL
207	NULL
bp	NULL
of	NULL
5	NULL
'	NULL
flanking	NULL
sequence	NULL
were	NULL
8	NULL
%	NULL
and	NULL
7	NULL
%	NULL
as	NULL
active	NULL
as	NULL
corresponding	NULL
full-length	NULL
constructs	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
HS2	NULL
and	NULL
uHS-40	NULL
&	NULL
(	NULL
-207	NULL
)	NULL
constructs	NULL
were	NULL
14	NULL
%	NULL
and	NULL
33	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
corresponding	NULL
full-length	NULL
constructs	NULL
(	NULL
Fig	NULL
3	NULL
,	NULL
B	NULL
and	NULL
D	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
an	NULL
enhancer	NULL
,	NULL
the	NULL
£	NULL
(	NULL
-207	NULL
)	NULL
construct	NULL
was	NULL
17	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
full-length	NULL
construct	NULL
,	NULL
showing	NULL
that	NULL
this	NULL
putative	NULL
positive	NULL
element	NULL
does	NULL
not	NULL
require	NULL
an	NULL
enhancer	NULL
for	NULL
its	NULL
function	NULL
(	NULL
Fig	NULL
3E	NULL
)	NULL
.	NULL

No	NULL
further	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
was	NULL
observed	NULL
when	NULL
additional	NULL
sequences	NULL
between	NULL
-207	NULL
and	NULL
-128	NULL
were	NULL
deleted	NULL
.	NULL

An	NULL
internal	NULL
deletion	NULL
from	NULL
-417	NULL
to	NULL
-207	NULL
resulted	NULL
in	NULL
the	NULL
same	NULL
loss	NULL
in	NULL
promoter	NULL
activity	NULL
as	NULL
the	NULL
5	NULL
'	NULL
terminal	NULL
deletion	NULL
to	NULL
-128	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
sequences	NULL
5	NULL
to	NULL
-417	NULL
SABATH	NULL
ET	NULL
AL	NULL
have	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
3F	NULL
)	NULL
.	NULL

No	NULL
evidence	NULL
for	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
was	NULL
found	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
located	NULL
between	NULL
-417	NULL
and	NULL
-207	NULL
5	NULL
``	NULL
to	NULL
the	NULL
{	NULL
-globin	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
designated	NULL
the	NULL
URE	NULL
.	NULL

This	NULL
element	NULL
acts	NULL
autonomously	NULL
because	NULL
it	NULL
does	NULL
not	NULL
require	NULL
an	NULL
enhancer	NULL
for	NULL
its	NULL
activity	NULL
.	NULL

To	NULL
determine	NULL
what	NULL
effect	NULL
these	NULL
deletions	NULL
of	NULL
the	NULL
E-globin	NULL
promoter	NULL
might	NULL
have	NULL
in	NULL
a	NULL
cell	NULL
line	NULL
that	NULL
does	NULL
not	NULL
express	NULL
L-globin	NULL
,	NULL
the	NULL
&	NULL
-	NULL
and	NULL
a-luciferase	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
OCIM1	NULL
cells	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
low	NULL
level	NULL
activity	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
in	NULL
OCIM1	NULL
cells	NULL
,	NULL
a-luciferase	NULL
constructs	NULL
were	NULL
included	NULL
in	NULL
each	NULL
experiment	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
given	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
-globin	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
highest	NULL
levels	NULL
of	NULL
E-luciferase	NULL
activity	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
HS-40	NULL
and	NULL
LHS-40	NULL
enhancers	NULL
.	NULL

With	NULL
these	NULL
enhancers	NULL
,	NULL
C-luciferase	NULL
activity	NULL
was	NULL
at	NULL
most	NULL
20	NULL
%	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
a-luciferase	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

With	NULL
uLCR	NULL
,	NULL
the	NULL
G-luciferase	NULL
constructs	NULL
were	NULL
at	NULL
most	NULL
5	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
-luciferase	NULL
constructs	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
,	NULL
with	NULL
HS2	NULL
,	NULL
the	NULL
E-luciferase	NULL
constructs	NULL
were	NULL
at	NULL
most	NULL
10	NULL
%	NULL
as	NULL
active	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
,	NULL
and	NULL
with	NULL
no	NULL
enhancer	NULL
,	NULL
the	NULL
C-luciferase	NULL
constructs	NULL
were	NULL
at	NULL
most	NULL
7	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
-luciferase	NULL
construct	NULL
(	NULL
Fig	NULL
4E	NULL
)	NULL
.	NULL

The	NULL
large	NULL
decrease	NULL
in	NULL
the	NULL
C-globin	NULL
promoter	NULL
activity	NULL
observed	NULL
with	NULL
deletion	NULL
of	NULL
the	NULL
URE	NULL
in	NULL
K562	NULL
cells	NULL
was	NULL
not	NULL
as	NULL
pronounced	NULL
in	NULL
the	NULL
OCIM1	NULL
cells	NULL
.	NULL

There	NULL
is	NULL
a	NULL
suggestion	NULL
that	NULL
the	NULL
-207	NULL
and	NULL
-128	NULL
constructs	NULL
have	NULL
less	NULL
activity	NULL
with	NULL
the	NULL
LCR	NULL
and	NULL
HS-40	NULL
enhancers	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
,	NULL
but	NULL
this	NULL
effect	NULL
is	NULL
not	NULL
seen	NULL
with	NULL
the	NULL
other	NULL
constructs	NULL
.	NULL

A	NULL
similar	NULL
small	NULL
decrease	NULL
in	NULL
activity	NULL
is	NULL
seen	NULL
with	NULL
the	NULL
-417	NULL
to	NULL
-207	NULL
internal	NULL
deletion	NULL
(	NULL
Fig	NULL
4F	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
because	NULL
of	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
{	NULL
-globin	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
OCIM1	NULL
cells	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
deletion	NULL
is	NULL
more	NULL
difficult	NULL
to	NULL
discern	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
of	NULL
luciferase	NULL
RNA	NULL
.	NULL

-	NULL
To	NULL
verify	NULL
that	NULL
the	NULL
physiologic	NULL
&	NULL
-globin	NULL
transcription	NULL
start	NULL
site	NULL
was	NULL
being	NULL
used	NULL
to	NULL
drive	NULL
luciferase	NULL
expression	NULL
,	NULL
primer	NULL
extension	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
oligonucleotide	NULL
primer	NULL
specific	NULL
for	NULL
luciferase	NULL
sequences	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
performed	NULL
on	NULL
RNA	NULL
transcripts	NULL
starting	NULL
at	NULL
the	NULL
physiologic	NULL
&	NULL
-globin	NULL
cap	NULL
site	NULL
produces	NULL
an	NULL
82	NULL
base	NULL
product	NULL
using	NULL
a	NULL
primer	NULL
complementary	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
luciferase	NULL
RNA	NULL
.	NULL

The	NULL
correct	NULL
82	NULL
base	NULL
product	NULL
was	NULL
produced	NULL
using	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
K562	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
-557	NULL
or	NULL
-417	NULL
C-luciferase	NULL
constructs	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

The	NULL
primer	NULL
extension	NULL
product	NULL
was	NULL
barely	NULL
detectable	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
-207	NULL
or	NULL
-128	NULL
constructs	NULL
,	NULL
showing	NULL
that	NULL
the	NULL
lower	NULL
levels	NULL
of	NULL
luciferase	NULL
obtained	NULL
were	NULL
due	NULL
to	NULL
lower	NULL
RNA	NULL
levels	NULL
.	NULL

As	NULL
with	NULL
the	NULL
K562	NULL
cells	NULL
,	NULL
correctly	NULL
initiated	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
OCIM	NULL
1	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
-557	NULL
and	NULL
-417	NULL
constructs	NULL
,	NULL
but	NULL
not	NULL
the	NULL
-207	NULL
or	NULL
-128	NULL
constructs	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
lower	NULL
levels	NULL
of	NULL
luciferase	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
uLCR	NULL
and	NULL
HS-40	NULL
constructs	NULL
containing	NULL
shorter	NULL
{	NULL
-globin	NULL
promoters	NULL
(	NULL
Fig	NULL
4	NULL
,	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
F	NULL
)	NULL
reflect	NULL
relatively	NULL
less	NULL
{	NULL
-globin	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
that	NULL
the	NULL
URE	NULL
has	NULL
some	NULL
activity	NULL
in	NULL
OCIM1	NULL
cells	NULL
.	NULL

Again	NULL
,	NULL
no	NULL
evidence	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
was	NULL
observed	NULL
.	NULL

The	NULL
URE	NULL
lacks	NULL
classical	NULL
enhancer	NULL
activity	NULL
.	NULL

-	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
URE	NULL
is	NULL
a	NULL
classical	NULL
enhancer	NULL
,	NULL
a	NULL
PCR	NULL
product	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

C-GLOBIN	NULL
UPSTREAM	NULL
REGULATORY	NULL
ELEMENT	NULL
2593	NULL
uLCR	NULL
HS2	NULL
HS-40	NULL
uHS-40	NULL
No	NULL
Enhancer	NULL
A	NULL
Ko	NULL
.	NULL

P	NULL
$	NULL
8	NULL
KX	NULL
.S	NULL
.P	NULL
A	NULL
Sbb	NULL
P	NULL
$	NULL
8	NULL
$	NULL
Qo	NULL
$	NULL
8	NULL
$	NULL
P	NULL
Fig	NULL
5	NULL
.	NULL

Primer	NULL
extension	NULL
anal-	NULL
FP	NULL
&	NULL
$	NULL
o	NULL
:	NULL
$	NULL
®	NULL
Poa	NULL
#	NULL
$	NULL
&	NULL
P	NULL
:	NULL
o_	NULL
®	NULL
F	NULL
_~	NULL
PVN	NULL
F	NULL
ysis	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
from	NULL
transfected	NULL
K562	NULL
ig	NULL
.w	NULL
'	NULL
(	NULL
A	NULL
)	NULL
or	NULL
OCIM1	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
was	NULL
used	NULL
“	NULL
9	NULL
S8	NULL
yor	NULL
%	NULL
«	NULL
#	NULL
”	NULL
Q	NULL
for	NULL
primer	NULL
extension	NULL
analysis	NULL
.	NULL

An	NULL
olend	NULL
labeled	NULL
Jusieraes	NULL
1020	NULL
B	NULL
4	NULL
500600	NULL
7	NULL
os	NULL
a	NULL
40	NULL
41	NULL
420	NULL
ds	NULL
:	NULL
44	NULL
45	NULL
460	NULL
47	NULL
18	NULL
19	NULL
20	NULL
oligonucleotide	NULL
primer	NULL
was	NULL
annealed	NULL
to	NULL
the	NULL
RNA	NULL
and	NULL
used	NULL
to	NULL
direct	NULL
cDNA	NULL
synthesis	NULL
using	NULL
AMV	NULL
reverse	NULL
transcriptase	NULL
.	NULL

The	NULL
B	NULL
No	NULL
Enh	NULL
cDNA	NULL
products	NULL
were	NULL
separated	NULL
uLCR	NULL
ase	NULL
Beso	NULL
uHS-40	NULL
o	NULL
Envancer	NULL
by	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
the	NULL
f	NULL
;	NULL
53	NULL
q	NULL
?	NULL

“	NULL
ﬂ	NULL
?	NULL

v3	NULL
?	NULL

y	NULL
'	NULL
i	NULL
‘	NULL
fé	NULL
‘	NULL
ﬂ	NULL
?	NULL

,	NULL
‘	NULL
;	NULL
\	NULL
>	NULL
<	NULL
\s|§	NULL
‘	NULL
5	NULL
``	NULL
?	NULL

,	NULL
``	NULL
3\	NULL
£6	NULL
‘	NULL
Lé	NULL
9	NULL
?	NULL

f	NULL
;	NULL
$	NULL
3	NULL
£194	NULL
£9	NULL
?	NULL

gel	NULL
was	NULL
dried	NULL
and	NULL
autoradiographed	NULL
.	NULL

Correctly	NULL
initiated	NULL
{	NULL
-luciferase	NULL
transcripts	NULL
result	NULL
in	NULL
a	NULL
sige	NULL
:	NULL
.	NULL

hf	NULL
.	NULL

cDNA	NULL
product	NULL
of	NULL
82	NULL
bases	NULL
{	NULL
arrows	NULL
)	NULL
.	NULL

21	NULL
22	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
29	NULL
30	NULL
31	NULL
32	NULL
33	NULL
34	NULL
35	NULL
36	NULL
37	NULL
38	NULL
39	NULL
40	NULL
spanning	NULL
nucleotides	NULL
-422	NULL
to	NULL
-163	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
CA	NULL
(	NULL
-417/-207	NULL
)	NULL
construct	NULL
in	NULL
its	NULL
physiologic	NULL
position	NULL
,	NULL
5	NULL
``	NULL
to	NULL
the	NULL
{	NULL
-globin	NULL
sequences	NULL
,	NULL
or	NULL
3	NULL
``	NULL
to	NULL
the	NULL
luciferase	NULL
and	NULL
SV40	NULL
sequences	NULL
in	NULL
both	NULL
sense	NULL
and	NULL
antisense	NULL
orientations	NULL
(	NULL
Fig	NULL
6A	NULL
)	NULL
.	NULL

The	NULL
HS-40	NULL
enhancer	NULL
was	NULL
included	NULL
in	NULL
these	NULL
constructs	NULL
to	NULL
increase	NULL
expression	NULL
.	NULL

Like	NULL
in	NULL
the	NULL
previous	NULL
experiments	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
luciferase	NULL
activity	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
RSV-	NULL
,	NULL
a-	NULL
,	NULL
and	NULL
wild-type	NULL
G-luciferase	NULL
constructs	NULL
;	NULL
the	NULL
CA	NULL
(	NULL
-417/-207	NULL
)	NULL
-luciferase	NULL
construct	NULL
was	NULL
6	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
wild-type	NULL
E-luciferase	NULL
construct	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

When	NULL
cloned	NULL
into	NULL
its	NULL
physiologic	NULL
position	NULL
in	NULL
the	NULL
sense	NULL
orientation	NULL
,	NULL
the	NULL
URE	NULL
PCR	NULL
product	NULL
increased	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
-207	NULL
)	NULL
-luciferase	NULL
construct	NULL
by	NULL
10-fold	NULL
(	NULL
Fig	NULL
6B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
cloned	NULL
in	NULL
the	NULL
antisense	NULL
orientation	NULL
,	NULL
or	NULL
in	NULL
the	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
positions	NULL
,	NULL
the	NULL
URE	NULL
PCR	NULL
product	NULL
failed	NULL
to	NULL
increase	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
construct	NULL
.	NULL

Therefore	NULL
,	NULL
although	NULL
this	NULL
element	NULL
has	NULL
a	NULL
strong	NULL
positive	NULL
effect	NULL
on	NULL
E-globin	NULL
promoter	NULL
activity	NULL
,	NULL
the	NULL
URE	NULL
only	NULL
functions	NULL
in	NULL
the	NULL
correct	NULL
site	NULL
and	NULL
orientation	NULL
,	NULL
and	NULL
thus	NULL
,	NULL
is	NULL
not	NULL
a	NULL
classical	NULL
enhancer	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
GATA-1	NULL
and	NULL
CCACC	NULL
sites	NULL
in	NULL
the	NULL
URE	NULL
.	NULL

-	NULL
Previous	NULL
work	NULL
by	NULL
others	NULL
has	NULL
shown	NULL
that	NULL
there	NULL
is	NULL
a	NULL
GATA-1	NULL
site	NULL
at	NULL
-230	NULL
in	NULL
the	NULL
-globin	NULL
promoter	NULL
that	NULL
binds	NULL
nuclear	NULL
proteins	NULL
from	NULL
erythroid	NULL
cells	NULL
(	NULL
presumably	NULL
GATA-1	NULL
)	NULL
,	NULL
and	NULL
that	NULL
there	NULL
is	NULL
a	NULL
CCACC	NULL
site	NULL
at	NULL
-240	NULL
that	NULL
binds	NULL
proteins	NULL
in	NULL
nonerythroid	NULL
cells	NULL
,	NULL
thought	NULL
to	NULL
be	NULL
Sp1	NULL
.	NULL

*	NULL
Furthermore	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
-230	NULL
GATA-1	NULL
site	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
decrease	NULL
activity	NULL
of	NULL
the	NULL
&	NULL
-globin	NULL
promoter	NULL
in	NULL
transient	NULL
transfection	NULL
.	NULL
``	NULL

To	NULL
reproduce	NULL
this	NULL
finding	NULL
,	NULL
and	NULL
to	NULL
determine	NULL
whether	NULL
GATA-1	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
URE	NULL
,	NULL
a	NULL
point	NULL
mutation	NULL
of	NULL
the	NULL
-230	NULL
GATA-1	NULL
site	NULL
in	NULL
the	NULL
E-luciferase	NULL
construct	NULL
was	NULL
made	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
(	NULL
Fig	NULL
7A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
to	NULL
determine	NULL
what	NULL
role	NULL
the	NULL
-240	NULL
CCACC	NULL
site	NULL
plays	NULL
,	NULL
if	NULL
any	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
this	NULL
site	NULL
was	NULL
made	NULL
.	NULL

The	NULL
two	NULL
mutations	NULL
were	NULL
combined	NULL
in	NULL
a	NULL
third	NULL
construct	NULL
.	NULL

The	NULL
HS-40	NULL
enhancer	NULL
was	NULL
included	NULL
to	NULL
increase	NULL
expression	NULL
,	NULL
because	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
activity	NULL
of	NULL
the	NULL
enhancerless	NULL
constructs	NULL
make	NULL
it	NULL
difficult	NULL
to	NULL
detect	NULL
small	NULL
magnitude	NULL
changes	NULL
in	NULL
promoter	NULL
activity	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
these	NULL
mutations	NULL
abolished	NULL
factor	NULL
binding	NULL
,	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
sequences	NULL
were	NULL
used	NULL
in	NULL
EMSA	NULL
.	NULL

When	NULL
the	NULL
mutant	NULL
-230	NULL
GATA-1	NULL
sequence	NULL
was	NULL
incubated	NULL
with	NULL
a	NULL
GST/GATA-1	NULL
fusion	NULL
protein	NULL
,	NULL
no	NULL
shifted	NULL
band	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
7B	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
an	NULL
intense	NULL
shifted	NULL
band	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
wild-type	NULL
probe	NULL
.	NULL

Unlabeled	NULL
wild-type	NULL
oligonucleotide	NULL
was	NULL
able	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
with	NULL
the	NULL
wild-type	NULL
probe	NULL
;	NULL
the	NULL
mutant	NULL
oligonucleotide	NULL
was	NULL
unable	NULL
to	NULL
compete	NULL
for	NULL
GST/GATA-1	NULL
binding	NULL
(	NULL
Fig	NULL
7B	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
crude	NULL
nuclear	NULL
extracts	NULL
from	NULL
K562	NULL
and	NULL
OCIM1	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
shows	NULL
that	NULL
the	NULL
mutation	NULL
eliminated	NULL
GATA-1	NULL
binding	NULL
.	NULL

When	NULL
the	NULL
wild-type	NULL
CCACC	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
an	NULL
EMSA	NULL
probe	NULL
,	NULL
only	NULL
faint	NULL
binding	NULL
of	NULL
proteins	NULL
in	NULL
K562	NULL
nuclear	NULL
extracts	NULL
was	NULL
observed	NULL
,	NULL
and	NULL
only	NULL
after	NULL
extended	NULL
autoradiography	NULL
(	NULL
Fig	NULL
7C	NULL
)	NULL
.	NULL

Nonethe-less	NULL
,	NULL
the	NULL
shifted	NULL
band	NULL
was	NULL
not	NULL
observed	NULL
when	NULL
the	NULL
mutant	NULL
-240	NULL
CCACC	NULL
sequence	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
the	NULL
wild-type	NULL
oligonucleotide	NULL
competed	NULL
for	NULL
binding	NULL
of	NULL
this	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
mutant	NULL
sequence	NULL
did	NULL
not	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
OCIM1	NULL
nuclear	NULL
extracts	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
this	NULL
complex	NULL
is	NULL
unknown	NULL
.	NULL

An	NULL
erythroid-specific	NULL
CCACC-binding	NULL
protein	NULL
,	NULL
EKLF	NULL
,	NULL
``	NULL
provided	NULL
as	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
,	NULL
did	NULL
not	NULL
bind	NULL
the	NULL
-240	NULL
CCACC	NULL
oligonucleotide	NULL
,	NULL
nor	NULL
did	NULL
recombinant	NULL
Spl	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
mutant	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
K562	NULL
and	NULL
OCIM1	NULL
cells	NULL
.	NULL

The	NULL
-240	NULL
CCACC	NULL
mutant	NULL
by	NULL
itself	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
-globin	NULL
promoter	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
mutation	NULL
even	NULL
seemed	NULL
to	NULL
increase	NULL
promoter	NULL
activity	NULL
somewhat	NULL
in	NULL
the	NULL
K562	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
the	NULL
OCIM1	NULL
cells	NULL
(	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL

The	NULL
-230	NULL
GATA-1	NULL
mutation	NULL
retained	NULL
67	NULL
%	NULL
of	NULL
the	NULL
wild-type	NULL
{	NULL
-globin	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
K562	NULL
cells	NULL
,	NULL
considerably	NULL
greater	NULL
than	NULL
the	NULL
10	NULL
%	NULL
of	NULL
wild-type	NULL
activity	NULL
obtained	NULL
with	NULL
the	NULL
-207	NULL
deletion	NULL
in	NULL
the	NULL
same	NULL
experiment	NULL
(	NULL
Fig	NULL
8A	NULL
)	NULL
.	NULL

In	NULL
the	NULL
OCIM1	NULL
cells	NULL
,	NULL
the	NULL
GATA-1	NULL
mutation	NULL
was	NULL
50	NULL
%	NULL
as	NULL
active	NULL
as	NULL
the	NULL
wild-type	NULL
promoter	NULL
(	NULL
Fig	NULL
8B	NULL
)	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
the	NULL
activity	NULL
was	NULL
greater	NULL
,	NULL
although	NULL
these	NULL
differences	NULL
are	NULL
difficult	NULL
to	NULL
interpret	NULL
because	NULL
the	NULL
wild-type	NULL
promoter	NULL
has	NULL
such	NULL
low	NULL
activity	NULL
in	NULL
OCIM1	NULL
cells	NULL
.	NULL

When	NULL
the	NULL
-240	NULL
CCACC	NULL
mutation	NULL
was	NULL
added	NULL
to	NULL
the	NULL
-230	NULL
GATA-1	NULL
mutation	NULL
,	NULL
no	NULL
additional	NULL
loss	NULL
in	NULL
promoter	NULL
activity	NULL
was	NULL
observed	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2594	NULL
A	NULL
417	NULL
-207	NULL
HS-40	NULL
A	NULL
,	NULL
ase	NULL
__SV40	NULL
Intron	NULL
and	NULL
Ap	NULL
Signal	NULL
HS-40A	NULL
(	NULL
-417/-207	NULL
)	NULL
Luc	NULL
w/z	NULL
{	NULL
Globin	NULL
5	NULL
Flanking	NULL
Region	NULL
~R	NULL
Le	NULL
RRR	NULL
HS-40	NULL
;	NULL
5URE	NULL
:	NULL
Luc	NULL
Le	NULL
Ce-	NULL
]	NULL
110	NULL
s	NULL
so	NULL
F	NULL
7	NULL
80	NULL
F	NULL
7	NULL
70	NULL
F	NULL
``	NULL
60	NULL
F	NULL
7	NULL
50	NULL
F	NULL
7	NULL
30	NULL
|	NULL
20	NULL
F	NULL
``	NULL
RC	NULL
=	NULL
Lo	NULL
=	NULL
Nar	NULL
CCC	NULL
$	NULL
%	NULL
£776	NULL
}	NULL
®¢®®¢	NULL
*	NULL
A	NULL
000	NULL
2	NULL
90	NULL
)	NULL
x	NULL
*	NULL
Luciferase/B-galactosidase	NULL
(	NULL
%	NULL
of	NULL
o-globin	NULL
promoter	NULL
activity	NULL
)	NULL
&	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Testing	NULL
the	NULL
URE	NULL
for	NULL
enhancer	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Constructs	NULL
used	NULL
to	NULL
test	NULL
enhancer	NULL
activity	NULL
of	NULL
the	NULL
URE	NULL
.	NULL

A	NULL
PCR	NULL
product	NULL
spanning	NULL
nucleotides	NULL
-422	NULL
to	NULL
-163	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
{	NULL
A	NULL
(	NULL
-417/-207	NULL
)	NULL
-luciferase	NULL
construct	NULL
at	NULL
its	NULL
physiologic	NULL
site	NULL
(	NULL
int	NULL
)	NULL
,	NULL
5°	NULL
to	NULL
{	NULL
-globin	NULL
sequences	NULL
(	NULL
5	NULL
'	NULL
)	NULL
,	NULL
and	NULL
3	NULL
'	NULL
to	NULL
luciferase	NULL
sequences	NULL
(	NULL
3	NULL
'	NULL
)	NULL
in	NULL
the	NULL
sense	NULL
(	NULL
+	NULL
)	NULL
and	NULL
antisense	NULL
(	NULL
-	NULL
)	NULL
orientations	NULL
.	NULL

HS-40	NULL
was	NULL
used	NULL
as	NULL
an	NULL
enhancer	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Results	NULL
of	NULL
transfection	NULL
of	NULL
K562	NULL
cells	NULL
with	NULL
URE	NULL
insertion	NULL
constructs	NULL
as	NULL
well	NULL
as	NULL
RSV-luciferase	NULL
,	NULL
eluciferase	NULL
,	NULL
wild-type	NULL
{	NULL
-luciferase	NULL
,	NULL
and	NULL
{	NULL
6	NULL
(	NULL
-417/-207	NULL
)	NULL
-lu-ciferase	NULL
constructs	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
2	NULL
.	NULL

Activities	NULL
of	NULL
the	NULL
various	NULL
constructs	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
«	NULL
-globin	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
-230	NULL
GATA-1	NULL
site	NULL
has	NULL
low	NULL
affinity	NULL
for	NULL
GATA-1	NULL
.	NULL

-	NULL
One	NULL
explanation	NULL
for	NULL
the	NULL
relatively	NULL
small	NULL
effect	NULL
of	NULL
the	NULL
-230	NULL
GATA-1	NULL
mutation	NULL
on	NULL
&	NULL
-globin	NULL
promoter	NULL
activity	NULL
is	NULL
that	NULL
the	NULL
-230	NULL
GATA-1	NULL
site	NULL
has	NULL
low	NULL
affinity	NULL
for	NULL
GATA-1	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
probe	NULL
for	NULL
the	NULL
-230	NULL
GATA-1	NULL
site	NULL
,	NULL
and	NULL
its	NULL
binding	NULL
activity	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
activities	NULL
of	NULL
two	NULL
other	NULL
GATA-1	NULL
sites	NULL
.	NULL

One	NULL
site	NULL
was	NULL
from	NULL
+2,392	NULL
in	NULL
the	NULL
B-globin	NULL
3	NULL
'	NULL
enhancer	NULL
.	NULL
``	NULL

The	NULL
other	NULL
was	NULL
the	NULL
GATA-1	NULL
site	NULL
located	NULL
at	NULL
-105	NULL
in	NULL
the	NULL
{	NULL
-globin	NULL
5	NULL
``	NULL
flanking	NULL
region	NULL
.	NULL

When	NULL
the	NULL
-230	NULL
GATA-1	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
with	NULL
K562	NULL
(	NULL
Fig	NULL
9A	NULL
)	NULL
and	NULL
OCIMI1	NULL
(	NULL
Fig	NULL
9B	NULL
)	NULL
nuclear	NULL
extracts	NULL
,	NULL
a	NULL
faint	NULL
band	NULL
was	NULL
obtained	NULL
.	NULL

The	NULL
-globin	NULL
3	NULL
'	NULL
enhancer	NULL
probe	NULL
SABATH	NULL
ET	NULL
AL	NULL
produced	NULL
a	NULL
band	NULL
of	NULL
moderate	NULL
intensity	NULL
,	NULL
and	NULL
the	NULL
-105	NULL
L-globin	NULL
GATA-1	NULL
site	NULL
produced	NULL
a	NULL
very	NULL
intense	NULL
band	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
.	NULL

When	NULL
used	NULL
as	NULL
an	NULL
unlabeled	NULL
competitor	NULL
in	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
,	NULL
the	NULL
-230	NULL
GATA-1	NULL
oligonucleotide	NULL
failed	NULL
to	NULL
compete	NULL
for	NULL
GATA-1	NULL
binding	NULL
with	NULL
either	NULL
the	NULL
3-globin	NULL
3	NULL
'	NULL
enhancer	NULL
probe	NULL
or	NULL
the	NULL
-105	NULL
&	NULL
-globin	NULL
probe	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
these	NULL
two	NULL
latter	NULL
oligonucleotides	NULL
competed	NULL
very	NULL
effectively	NULL
with	NULL
the	NULL
-230	NULL
probe	NULL
for	NULL
binding	NULL
.	NULL

The	NULL
3-globin	NULL
3	NULL
'	NULL
enhancer	NULL
oligonucleotide	NULL
had	NULL
partial	NULL
activity	NULL
in	NULL
competing	NULL
for	NULL
the	NULL
-105	NULL
{	NULL
-globin	NULL
GATA-1	NULL
complex	NULL
,	NULL
whereas	NULL
the	NULL
-105	NULL
site	NULL
competed	NULL
efficiently	NULL
for	NULL
GATA-1	NULL
binding	NULL
to	NULL
the	NULL
3-globin	NULL
3	NULL
'	NULL
enhancer	NULL
probe	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
experiments	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
GATA-1	NULL
for	NULL
the	NULL
three	NULL
different	NULL
GATA-1	NULL
sites	NULL
is	NULL
-105	NULL
{	NULL
-globin	NULL
greater	NULL
than	NULL
B-globin	NULL
3	NULL
``	NULL
enhancer	NULL
greater	NULL
than	NULL
-230	NULL
C-globin	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
upstream	NULL
C-globin	NULL
promoter	NULL
using	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
promoter	NULL
to	NULL
drive	NULL
luciferase	NULL
expression	NULL
in	NULL
transiently	NULL
transfected	NULL
erythroleu-kemic	NULL
cell	NULL
lines	NULL
that	NULL
had	NULL
different	NULL
patterns	NULL
of	NULL
globin	NULL
expression	NULL
.	NULL

The	NULL
{	NULL
-globin	NULL
promoter	NULL
was	NULL
active	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
which	NULL
contain	NULL
C-globin	NULL
RNA	NULL
,	NULL
and	NULL
was	NULL
less	NULL
active	NULL
in	NULL
OCIM1	NULL
cells	NULL
,	NULL
which	NULL
do	NULL
not	NULL
contain	NULL
detectable	NULL
{	NULL
-globin	NULL
RNA	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
-globin	NULL
promoter	NULL
was	NULL
active	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
,	NULL
both	NULL
of	NULL
which	NULL
contain	NULL
a-globin	NULL
RNA	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
novel	NULL
positive	NULL
regulatory	NULL
element	NULL
in	NULL
the	NULL
region	NULL
between	NULL
417	NULL
and	NULL
207	NULL
bp	NULL
5	NULL
'	NULL
to	NULL
the	NULL
C-globin	NULL
RNA	NULL
cap	NULL
site	NULL
that	NULL
is	NULL
necessary	NULL
for	NULL
high-level	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
which	NULL
we	NULL
have	NULL
designated	NULL
the	NULL
URE	NULL
.	NULL

This	NULL
element	NULL
is	NULL
not	NULL
a	NULL
classical	NULL
enhancer	NULL
,	NULL
in	NULL
that	NULL
its	NULL
function	NULL
is	NULL
position-	NULL
and	NULL
orientation-dependent	NULL
.	NULL

The	NULL
URE	NULL
also	NULL
appears	NULL
to	NULL
have	NULL
activity	NULL
in	NULL
OCIM1	NULL
cells	NULL
,	NULL
but	NULL
because	NULL
the	NULL
baseline	NULL
promoter	NULL
activity	NULL
was	NULL
low	NULL
in	NULL
the	NULL
OCIM1	NULL
cells	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
positive	NULL
regulatory	NULL
element	NULL
was	NULL
less	NULL
dramatic	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
URE	NULL
is	NULL
an	NULL
autonomous	NULL
property	NULL
of	NULL
the	NULL
&	NULL
-globin	NULL
promoter	NULL
because	NULL
deletion	NULL
of	NULL
the	NULL
URE	NULL
results	NULL
in	NULL
a	NULL
significant	NULL
decrease	NULL
in	NULL
C-luciferase	NULL
activity	NULL
regardless	NULL
of	NULL
what	NULL
enhancer	NULL
,	NULL
if	NULL
any	NULL
,	NULL
is	NULL
used	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
study	NULL
by	NULL
Zhang	NULL
et	NULL
al	NULL
``	NULL
a	NULL
deletion	NULL
from	NULL
-557	NULL
to	NULL
-88	NULL
caused	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
{	NULL
-globin	NULL
promoter	NULL
activity	NULL
,	NULL
but	NULL
the	NULL
effect	NULL
was	NULL
only	NULL
observed	NULL
when	NULL
the	NULL
promoter	NULL
was	NULL
linked	NULL
to	NULL
the	NULL
HS-40	NULL
core	NULL
enhancer	NULL
.	NULL

Because	NULL
the	NULL
data	NULL
presented	NULL
in	NULL
the	NULL
current	NULL
study	NULL
show	NULL
that	NULL
an	NULL
enhancer	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
the	NULL
URE	NULL
,	NULL
combining	NULL
these	NULL
data	NULL
with	NULL
those	NULL
of	NULL
Zhang	NULL
et	NULL
al	NULL
suggests	NULL
that	NULL
enhancer	NULL
sequences	NULL
may	NULL
interact	NULL
with	NULL
the	NULL
proximal	NULL
promoter	NULL
in	NULL
the	NULL
region	NULL
between	NULL
-128	NULL
and	NULL
-88	NULL
.	NULL

Our	NULL
original	NULL
hypothesis	NULL
had	NULL
been	NULL
that	NULL
the	NULL
GATA-1	NULL
site	NULL
at	NULL
-230	NULL
or	NULL
the	NULL
CCACC	NULL
site	NULL
at	NULL
-240	NULL
would	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
positive	NULL
regulatory	NULL
activity	NULL
in	NULL
the	NULL
-417	NULL
to	NULL
-207	NULL
region	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
-230	NULL
GATA-1	NULL
mutation	NULL
reduced	NULL
the	NULL
{	NULL
-globin	NULL
promoter	NULL
activity	NULL
by	NULL
only	NULL
37	NULL
%	NULL
,	NULL
compared	NULL
with	NULL
the	NULL
90	NULL
%	NULL
decrease	NULL
activity	NULL
observed	NULL
with	NULL
the	NULL
full	NULL
deletion	NULL
.	NULL

The	NULL
-240	NULL
CCACC	NULL
site	NULL
mutation	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

The	NULL
EMSA	NULL
comparing	NULL
the	NULL
-230	NULL
GATA-1	NULL
site	NULL
to	NULL
two	NULL
other	NULL
GATA-1	NULL
sites	NULL
suggests	NULL
that	NULL
GATA-1	NULL
has	NULL
low	NULL
affinity	NULL
for	NULL
this	NULL
site	NULL
.	NULL

If	NULL
this	NULL
is	NULL
the	NULL
case	NULL
,	NULL
even	NULL
if	NULL
GATA-1	NULL
activates	NULL
the	NULL
promoter	NULL
when	NULL
it	NULL
binds	NULL
at	NULL
-230	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
this	NULL
site	NULL
is	NULL
only	NULL
partially	NULL
occupied	NULL
by	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

C-GLOBIN	NULL
UPSTREAM	NULL
REGULATORY	NULL
ELEMENT	NULL
Fig	NULL
7	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
-230	NULL
GATA-1	NULL
and	NULL
-240	NULL
CCACC	NULL
sites	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
-249	NULL
to	NULL
-223	NULL
region	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
showing	NULL
the	NULL
mutations	NULL
introduced	NULL
by	NULL
PCR	NULL
mutagenesis	NULL
.	NULL

The	NULL
GATA-1	NULL
and	NULL
CCACC	NULL
sites	NULL
are	NULL
underlined	NULL
;	NULL
note	NULL
that	NULL
the	NULL
sites	NULL
are	NULL
encoded	NULL
on	NULL
the	NULL
antisense	NULL
B	NULL
strand	NULL
.	NULL

Mutated	NULL
sequences	NULL
are	NULL
indicated	NULL
by	NULL
lower	NULL
2595	NULL
T-Globin	NULL
5	NULL
``	NULL
flanking	NULL
region	NULL
Lue	NULL
*	NULL
ns-40	NULL
«	NULL
557	NULL
-249	NULL
-223	NULL
...	NULL
TGGGAGGGTGGGGCCCCTATCTCTCCT	NULL
...	NULL
thsen	NULL
)	NULL
/	NULL
wi	NULL
...	NULL
TGGGAGGGTGGEGCCCETAgagCTCCt	NULL
...	NULL
...	NULL
TGGGAtecTGGSGCCCCTATCTCTCCT	NULL
...	NULL
...	NULL
TGGGAtccT6GGGCCCCTAgagCTCCT	NULL
...	NULL
C	NULL
case	NULL
letters	NULL
.	NULL

The	NULL
mutated	NULL
promoter	NULL
sequences	NULL
were	NULL
=	NULL
prope	NULL
:	NULL
a	NULL
“	NULL
é	NULL
``	NULL
incorporated	NULL
into	NULL
luciferase	NULL
plasmids	NULL
with	NULL
the	NULL
HS-40	NULL
ff	NULL
P+	NULL
A	NULL
A	NULL
49,0	NULL
;	NULL
50°	NULL
enhancer	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
using	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
_	NULL
°	NULL
``	NULL
ra	NULL
A	NULL
A	NULL
-230	NULL
GATA-1	NULL
sequences	NULL
as	NULL
probes	NULL
and	NULL
competitors	NULL
.	NULL

{	NULL
if	NULL
if	NULL
$	NULL
$	NULL
g	NULL
ﬁ	NULL
'	NULL
if	NULL
if	NULL
¢	NULL
¢	NULL
&	NULL
f	NULL
¢	NULL
&	NULL
&	NULL
9	NULL
The	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
recombinant	NULL
GST/	NULL
GATA-1	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
a	NULL
10-	NULL
or	NULL
100-fold	NULL
molar	NULL
excess	NULL
over	NULL
probe	NULL
oligonucleotide	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
radiolabeled	NULL
probes	NULL
.	NULL

The	NULL
specific	NULL
GST/GATA-1	NULL
complex	NULL
with	NULL
DNA	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
using	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
CCACC	NULL
sequences	NULL
as	NULL
probes	NULL
and	NULL
competitors	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
B	NULL
,	NULL
except	NULL
that	NULL
crude	NULL
K562	NULL
nuclear	NULL
extracts	NULL
and	NULL
nonspecific	NULL
competitor	NULL
DNA	NULL
was	NULL
used	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
specific	NULL
band	NULL
formed	NULL
between	NULL
the	NULL
wild-type	NULL
probe	NULL
and	NULL
a	NULL
factor	NULL
in	NULL
the	NULL
K562	NULL
nuclear	NULL
extract	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
arrow	NULL
.	NULL

The	NULL
autoradiograph	NULL
was	NULL
exposed	NULL
for	NULL
7	NULL
days	NULL
at	NULL
-70°C	NULL
with	NULL
intensifying	NULL
screens	NULL
.	NULL

GATA-1	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
so	NULL
removing	NULL
GATA-1	NULL
has	NULL
only	NULL
a	NULL
partial	NULL
negative	NULL
effect	NULL
on	NULL
promoter	NULL
activity	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
human	NULL
-417	NULL
to	NULL
-207	NULL
region	NULL
to	NULL
corresponding	NULL
regions	NULL
of	NULL
other	NULL
species	NULL
'	NULL
{	NULL
-globin	NULL
5	NULL
'	NULL
flanking	NULL
regions	NULL
shows	NULL
some	NULL
areas	NULL
of	NULL
identity	NULL
,	NULL
but	NULL
none	NULL
that	NULL
correspond	NULL
to	NULL
any	NULL
known	NULL
erythroid	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
the	NULL
URE	NULL
contains	NULL
binding	NULL
sites	NULL
for	NULL
proteins	NULL
that	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
globin	NULL
expression	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
5	NULL
``	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
&	NULL
-globin	NULL
pseu-dogene	NULL
,	NULL
{	NULL
1	NULL
,	NULL
lacks	NULL
this	NULL
URE	NULL
.	NULL
``	NULL

This	NULL
provides	NULL
an	NULL
explanation	NULL
for	NULL
some	NULL
earlier	NULL
studies	NULL
in	NULL
which	NULL
the	NULL
C1	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
{	NULL
-globin	NULL
coding	NULL
regions	NULL
,	NULL
but	NULL
failed	NULL
to	NULL
direct	NULL
RNA	NULL
transcription	NULL
.	NULL
``	NULL

While	NULL
the	NULL
URE	NULL
is	NULL
important	NULL
for	NULL
high-level	NULL
promoter	NULL
A	NULL
B	NULL
``	NULL
u	NULL
(	NULL
Z	NULL
GSTGATA1	NULL
-	NULL
»	NULL
.	NULL

Cd	NULL
=	NULL
«	NULL
Free	NULL
probe	NULL
--	NULL
i	NULL
»	NULL
.	NULL

Free	NULL
probe	NULL
--	NULL
i	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
activity	NULL
,	NULL
it	NULL
is	NULL
most	NULL
likely	NULL
not	NULL
important	NULL
for	NULL
developmental	NULL
regulation	NULL
of	NULL
E-globin	NULL
,	NULL
because	NULL
constructs	NULL
lacking	NULL
these	NULL
sequences	NULL
are	NULL
expressed	NULL
in	NULL
a	NULL
developmentally	NULL
regulated	NULL
fashion	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL
``	NULL

Because	NULL
the	NULL
embryonic	NULL
3-like	NULL
globin	NULL
gene	NULL
,	NULL
e	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
a	NULL
developmental	NULL
silencer	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
,	NULL
``	NULL
*	NULL
it	NULL
is	NULL
significant	NULL
that	NULL
deletion	NULL
of	NULL
various	NULL
portions	NULL
of	NULL
the	NULL
5	NULL
``	NULL
flanking	NULL
region	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
increasing	NULL
&	NULL
-promoter	NULL
activity	NULL
in	NULL
K562	NULL
or	NULL
OCIM	NULL
1	NULL
cells	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
an	NULL
obvious	NULL
silencer	NULL
is	NULL
consistent	NULL
with	NULL
observations	NULL
made	NULL
using	NULL
transgenic	NULL
mouse	NULL
and	NULL
stable	NULL
transfection	NULL
systems	NULL
.	NULL
``	NULL

A	NULL
silencer	NULL
may	NULL
still	NULL
exist	NULL
in	NULL
the	NULL
proximal	NULL
{	NULL
-globin	NULL
promoter	NULL
.	NULL

Constructs	NULL
containing	NULL
smaller	NULL
deletions	NULL
that	NULL
retain	NULL
the	NULL
URE	NULL
may	NULL
be	NULL
able	NULL
to	NULL
show	NULL
such	NULL
an	NULL
element	NULL
.	NULL

210	NULL
awl-J	NULL
’	NULL
-£51801	NULL
1120	NULL
B	NULL
>	NULL
8	NULL
§	NULL
100	NULL
100	NULL
8	NULL
5	NULL
m	NULL
§	NULL
80	NULL
Bo	NULL
9	NULL
E	NULL
«	NULL
&	NULL
6	NULL
co	NULL
60	NULL
$	NULL
&	NULL
a	NULL
38	NULL
$	NULL
5	NULL
4	NULL
40	NULL
S	NULL
m	NULL
»	NULL
20	NULL
20	NULL
3	NULL
&	NULL
0	NULL
0	NULL
¢	NULL
I	NULL
}	NULL
$	NULL
0,500	NULL
)	NULL
a	NULL
?	NULL

3	NULL
,	NULL
40440	NULL
)	NULL
'	NULL
a	NULL
To	NULL
QQQQQOQS	NULL
}	NULL
E	NULL
*	NULL
%	NULL
y*	NULL
y*	NULL
Fig	NULL
8	NULL
.	NULL

Effect	NULL
of	NULL
point	NULL
mutations	NULL
on	NULL
{	NULL
-globin	NULL
promoter	NULL
activity	NULL
in	NULL
K562	NULL
(	NULL
A	NULL
)	NULL
and	NULL
OCIM1	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
.	NULL

See	NULL
Fig	NULL
7A	NULL
for	NULL
the	NULL
structures	NULL
of	NULL
the	NULL
mutant	NULL
constructs	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transfected	NULL
and	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
2	NULL
.	NULL

The	NULL
three	NULL
mutant	NULL
constructs	NULL
were	NULL
used	NULL
along	NULL
with	NULL
the	NULL
RSV	NULL
,	NULL
«	NULL
-globin	NULL
,	NULL
{	NULL
(	NULL
-557	NULL
)	NULL
and	NULL
{	NULL
(	NULL
-207	NULL
)	NULL
constructs	NULL
.	NULL

Activities	NULL
(	NULL
a	NULL
)	NULL
of	NULL
the	NULL
various	NULL
constructs	NULL
are	NULL
shown	NULL
as	NULL
a	NULL
percentage	NULL
To	NULL
-	NULL
of	NULL
«	NULL
-globin	NULL
promoter	NULL
activity	NULL
.	NULL

y	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2596	NULL
A	NULL
B	NULL
Probe	NULL
:	NULL
-230	NULL
GATA	NULL
$	NULL
3	NULL
'	NULL
Enhancer	NULL
t	NULL
(	NULL
-123/84	NULL
)	NULL
+230	NULL
GATA	NULL
SABATH	NULL
ET	NULL
AL	NULL
Fig	NULL
9	NULL
.	NULL

-	NULL
EMSAs	NULL
comparing	NULL
var-	NULL
B3	NULL
'	NULL
Enhancer	NULL
t-123-84	NULL
)	NULL
ious	NULL
GATA-1	NULL
binding	NULL
-	NULL
sites	NULL
.	NULL

-	NULL
Fog	NULL
4	NULL
#	NULL
&	NULL
_	NULL
»	NULL
Competitor	NULL
:	NULL
&	NULL
a	NULL
?	NULL

$	NULL
C	NULL
uS	NULL
is	NULL
C	NULL
$	NULL
is	NULL
C	NULL
#	NULL
EC	NULL
LSP	NULL
&	NULL
C	NULL
LCP	NULL
&	NULL
&	NULL
K562	NULL
Nuclear	NULL
Extract	NULL
ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Dr	NULL
S.M	NULL
.	NULL

Jane	NULL
for	NULL
the	NULL
K562	NULL
cells	NULL
,	NULL
Dr	NULL
Th	NULL
.	NULL

Papayannopoulou	NULL
for	NULL
the	NULL
OCIM1	NULL
cells	NULL
,	NULL
Dr	NULL
S.A.	NULL
Liebhaber	NULL
for	NULL
the	NULL
-globin	NULL
RNAase	NULL
protection	NULL
probe	NULL
,	NULL
Dr	NULL
E.M.	NULL
Rubin	NULL
for	NULL
the	NULL
-globin	NULL
genomic	NULL
clone	NULL
,	NULL
Dr	NULL
D.R	NULL
.	NULL

Higgs	NULL
for	NULL
the	NULL
plasmid	NULL
containing	NULL
HS-40	NULL
,	NULL
Dr	NULL
J.	NULL
Bieker	NULL
for	NULL
the	NULL
recombinant	NULL
GST/EKLF	NULL
fusion	NULL
protein	NULL
,	NULL
Dr	NULL
D.I.K	NULL
.	NULL

Martin	NULL
for	NULL
the	NULL
recombinant	NULL
GST/GATA-1	NULL
fusion	NULL
protein	NULL
and	NULL
the	NULL
3-globin	NULL
3	NULL
'	NULL
enhancer	NULL
oligonucleotide	NULL
,	NULL
and	NULL
Dr	NULL
S.	NULL
Orellana	NULL
for	NULL
her	NULL
assistance	NULL
with	NULL
initial	NULL
transfection	NULL
experiments	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Spangler	NULL
EA	NULL
,	NULL
Andrews	NULL
KA	NULL
,	NULL
Rubin	NULL
EM	NULL
:	NULL
Developmental	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
zeta	NULL
globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
18:7093	NULL
,	NULL
1990	NULL
2	NULL
.	NULL

Pondel	NULL
MD	NULL
,	NULL
Proudfoot	NULL
NJ	NULL
,	NULL
Whitelaw	NULL
C	NULL
,	NULL
Whitelaw	NULL
E	NULL
:	NULL
The	NULL
developmental	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
-globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
employing	NULL
3-galactosidase	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
20:5655	NULL
,	NULL
1992	NULL
3	NULL
.	NULL

Sabath	NULL
DE	NULL
,	NULL
Spangler	NULL
EA	NULL
,	NULL
Rubin	NULL
EM	NULL
,	NULL
Stamatoyannopoulos	NULL
G	NULL
:	NULL
Analysis	NULL
of	NULL
the	NULL
human	NULL
&	NULL
-globin	NULL
gene	NULL
promoter	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Blood	NULL
82:2899	NULL
,	NULL
1993	NULL
4	NULL
.	NULL

Lamb	NULL
P	NULL
,	NULL
Watt	NULL
P	NULL
,	NULL
Proudfoot	NULL
NJ	NULL
:	NULL
Negative	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
embryonic	NULL
globin	NULL
genes	NULL
&	NULL
and	NULL
e.	NULL
Prog	NULL
Clin	NULL
Biol	NULL
Res	NULL
316A:269	NULL
,	NULL
1989	NULL
5	NULL
.	NULL

Watt	NULL
P	NULL
,	NULL
Lamb	NULL
P	NULL
,	NULL
Proudfoot	NULL
NJ	NULL
:	NULL
Distinct	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
embryonic	NULL
globin	NULL
genes	NULL
&	NULL
and	NULL
e.	NULL
Gene	NULL
Exp	NULL
3:61	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Cao	NULL
SX	NULL
,	NULL
Gutman	NULL
PD	NULL
,	NULL
Dave	NULL
HPG	NULL
,	NULL
Schechter	NULL
AN	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
transcriptional	NULL
silencer	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
e-globin	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:5306	NULL
,	NULL
1989	NULL
7	NULL
.	NULL

Raich	NULL
N	NULL
,	NULL
Papayannopoulou	NULL
T	NULL
,	NULL
Stamatoyannopoulos	NULL
G	NULL
,	NULL
Enver	NULL
T	NULL
:	NULL
Demonstration	NULL
of	NULL
a	NULL
human	NULL
e-globin	NULL
gene	NULL
silencer	NULL
with	NULL
studies	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Blood	NULL
79:861	NULL
,	NULL
1992	NULL
8	NULL
.	NULL

Wada-Kiyama	NULL
Y	NULL
,	NULL
Peters	NULL
B	NULL
,	NULL
Noguchi	NULL
CT	NULL
:	NULL
The	NULL
e-globin	NULL
gene	NULL
silencer	NULL
:	NULL
Characterization	NULL
by	NULL
in	NULL
vitro	NULL
transcription	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:11532	NULL
,	NULL
1992	NULL
9	NULL
.	NULL

Vyas	NULL
P	NULL
,	NULL
Sharpe	NULL
JA	NULL
,	NULL
Watt	NULL
P	NULL
,	NULL
Higgs	NULL
DR	NULL
,	NULL
Wood	NULL
WG	NULL
:	NULL
Regulation	NULL
of	NULL
human	NULL
embryonic	NULL
globin	NULL
genes	NULL
£2	NULL
and	NULL
e	NULL
in	NULL
stably	NULL
transformed	NULL
mouse	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Blood	NULL
80:1832	NULL
,	NULL
1992	NULL
10	NULL
.	NULL

Higgs	NULL
DR	NULL
,	NULL
Wood	NULL
WG	NULL
,	NULL
Jarman	NULL
AP	NULL
,	NULL
Sharpe	NULL
J	NULL
,	NULL
Lida	NULL
J	NULL
,	NULL
Pretorius	NULL
I-M	NULL
,	NULL
Ayyub	NULL
H	NULL
:	NULL
A	NULL
major	NULL
positive	NULL
regulatory	NULL
region	NULL
located	NULL
far	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
a-globin	NULL
locus	NULL
.	NULL

Genes	NULL
Dev	NULL
4:1588	NULL
,	NULL
1990	NULL
C	NULL
o	NULL
a	NULL
»	NULL
3	NULL
&	NULL
CP	NULL
CL	NULL
ZP	NULL
C	NULL
&	NULL
&	NULL
P	NULL
Crude	NULL
nuclear	NULL
extracts	NULL
from	NULL
¢	NULL
.	NULL

$	NULL
&	NULL
K562	NULL
(	NULL
A	NULL
)	NULL
or	NULL
OCIM1	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
were	NULL
€	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
radiolabeled	NULL
probes	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
over	NULL
probe	NULL
oligonucleotide	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

The	NULL
probes	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
-230	NULL
GATA	NULL
,	NULL
GATA-1	NULL
site	NULL
from	NULL
the	NULL
i-globin	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
;	NULL
3	NULL
3	NULL
'	NULL
enhancer	NULL
,	NULL
GATA-1	NULL
site	NULL
from	NULL
coordinate	NULL
+2,392	NULL
in	NULL
the	NULL
B-globin	NULL
3	NULL
'	NULL
enhancer	NULL
;	NULL
``	NULL
``	NULL
{	NULL
(	NULL
-123/-84	NULL
)	NULL
,	NULL
a	NULL
40-bp	NULL
oligonucleotide	NULL
spanning	NULL
nucleotides	NULL
-123	NULL
to	NULL
-84	NULL
of	NULL
the	NULL
proximal	NULL
{	NULL
-globin	NULL
promoter	NULL
,	NULL
including	NULL
the	NULL
GATA-1	NULL
site	NULL
at	NULL
-105	NULL
.	NULL

OCIM1	NULL
Nuclear	NULL
Extract	NULL
11	NULL
.	NULL

Jarman	NULL
AP	NULL
,	NULL
Wood	NULL
WG	NULL
,	NULL
Sharpe	NULL
JA	NULL
,	NULL
Gourdon	NULL
G	NULL
,	NULL
Ayyub	NULL
H	NULL
,	NULL
Higgs	NULL
DR	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
major	NULL
regulatory	NULL
element	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
-globin	NULL
gene	NULL
cluster	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:4679	NULL
,	NULL
1991	NULL
12	NULL
.	NULL

Zhang	NULL
Q	NULL
,	NULL
Reddy	NULL
PMS	NULL
,	NULL
Yu	NULL
C	NULL
,	NULL
Bastiani	NULL
C	NULL
,	NULL
Higgs	NULL
D	NULL
,	NULL
Stamatoyannopoulos	NULL
G	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T	NULL
,	NULL
Shen	NULL
,	NULL
C	NULL
:	NULL
Transcriptional	NULL
activation	NULL
of	NULL
human	NULL
£2	NULL
globin	NULL
promoter	NULL
by	NULL
the	NULL
a	NULL
globin	NULL
regulatory	NULL
element	NULL
(	NULL
HS-40	NULL
)	NULL
:	NULL
Functional	NULL
role	NULL
of	NULL
specific	NULL
nuclear	NULL
factor-DNA	NULL
complexes	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:2298	NULL
,	NULL
1993	NULL
13	NULL
.	NULL

Rutherford	NULL
TR	NULL
,	NULL
Clegg	NULL
JB	NULL
,	NULL
Weatherall	NULL
DJ	NULL
:	NULL
K562	NULL
human	NULL
leukemia	NULL
cells	NULL
synthesize	NULL
embryonic	NULL
hemoglobin	NULL
in	NULL
response	NULL
to	NULL
hemin	NULL
.	NULL

Nature	NULL
280:164	NULL
,	NULL
1979	NULL
14	NULL
.	NULL

Papayannopoulou	NULL
T	NULL
,	NULL
Nakamoto	NULL
B	NULL
,	NULL
Kurachi	NULL
S	NULL
,	NULL
Nelson	NULL
R	NULL
:	NULL
Analysis	NULL
of	NULL
the	NULL
erythroid	NULL
phenotype	NULL
of	NULL
HEL	NULL
cells	NULL
:	NULL
Clonal	NULL
variation	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
inducers	NULL
.	NULL

Blood	NULL
70:1764	NULL
,	NULL
1987	NULL
15	NULL
.	NULL

Enver	NULL
T	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Anagnou	NULL
NP	NULL
,	NULL
Stamatoyannopoulos	NULL
G	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T	NULL
:	NULL
Developmental	NULL
programs	NULL
of	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
:	NULL
Globin	NULL
gene	NULL
expression	NULL
and	NULL
methylation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:4917	NULL
,	NULL
1988	NULL
16	NULL
.	NULL

Papayannopoulou	NULL
,	NULL
T	NULL
,	NULL
Nakamoto	NULL
,	NULL
B	NULL
,	NULL
Kurachi	NULL
,	NULL
S	NULL
,	NULL
Tweeddale	NULL
,	NULL
M	NULL
,	NULL
Messner	NULL
,	NULL
H	NULL
:	NULL
Surface	NULL
antigenic	NULL
profile	NULL
and	NULL
globin	NULL
phenotype	NULL
of	NULL
two	NULL
new	NULL
human	NULL
erythroleukemia	NULL
lines	NULL
:	NULL
Characterization	NULL
and	NULL
inter-pretations	NULL
.	NULL

Blood	NULL
72:1029	NULL
,	NULL
1988	NULL
17	NULL
.	NULL

Benz	NULL
EJ	NULL
,	NULL
Murnane	NULL
MJ	NULL
,	NULL
Tonkonow	NULL
BL	NULL
,	NULL
Berman	NULL
BW	NULL
,	NULL
Mazur	NULL
EM	NULL
,	NULL
Cavallesco	NULL
C	NULL
,	NULL
Jenko	NULL
T	NULL
,	NULL
Snyder	NULL
EL	NULL
,	NULL
Forget	NULL
BG	NULL
,	NULL
Hoffman	NULL
R	NULL
:	NULL
Embryonic-fetal	NULL
erythroid	NULL
characteristics	NULL
of	NULL
a	NULL
human	NULL
erythroleu-kemic	NULL
cell	NULL
line	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
77:3509	NULL
,	NULL
1980	NULL
18	NULL
.	NULL

Charnay	NULL
P	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
globin	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
human	NULL
erythroid	NULL
cell	NULL
line	NULL
K562	NULL
.	NULL

Science	NULL
220:1281	NULL
,	NULL
1983	NULL
19	NULL
.	NULL

Lozzio	NULL
CB	NULL
,	NULL
Lozzio	NULL
BB	NULL
:	NULL
Human	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
cell-line	NULL
with	NULL
positive	NULL
Philadelphia	NULL
chromosome	NULL
.	NULL

Blood	NULL
45:321	NULL
,	NULL
1975	NULL
20.	NULL
de	NULL
Wet	NULL
JR	NULL
,	NULL
Wood	NULL
KV	NULL
,	NULL
DeLuca	NULL
M	NULL
,	NULL
Helinski	NULL
DR	NULL
,	NULL
Subramani	NULL
S	NULL
:	NULL
Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
Structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
7:725	NULL
,	NULL
1987	NULL
21	NULL
.	NULL

Gorman	NULL
CM	NULL
,	NULL
Merlino	NULL
GT	NULL
,	NULL
Willingham	NULL
MC	NULL
,	NULL
Pastan	NULL
I	NULL
,	NULL
Howard	NULL
BH	NULL
:	NULL
The	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
is	NULL
a	NULL
strong	NULL
promoter	NULL
when	NULL
introduced	NULL
into	NULL
a	NULL
variety	NULL
of	NULL
eukaryotic	NULL
cells	NULL
by	NULL
DNA-mediated	NULL
transfection	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
79:6777	NULL
,	NULL
1982	NULL
22	NULL
.	NULL

Subramani	NULL
S	NULL
,	NULL
Southern	NULL
PJ	NULL
:	NULL
Analysis	NULL
of	NULL
gene	NULL
expression	NULL
using	NULL
simian	NULL
virus	NULL
40	NULL
vectors	NULL
.	NULL

Anal	NULL
Biochem	NULL
135:1	NULL
,	NULL
1983	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

C-GLOBIN	NULL
UPSTREAM	NULL
REGULATORY	NULL
ELEMENT	NULL
23	NULL
.	NULL

Edlund	NULL
T	NULL
,	NULL
Walker	NULL
MD	NULL
,	NULL
Barr	NULL
PJ	NULL
,	NULL
Rutter	NULL
WJ	NULL
;	NULL
Cell-specific	NULL
expression	NULL
of	NULL
the	NULL
rat	NULL
insulin	NULL
gene	NULL
:	NULL
Evidence	NULL
for	NULL
role	NULL
of	NULL
two	NULL
distinct	NULL
5	NULL
'	NULL
flanking	NULL
elements	NULL
.	NULL

Science	NULL
230:912	NULL
,	NULL
1985	NULL
24	NULL
.	NULL

Curtin	NULL
PT	NULL
,	NULL
Lin	NULL
D	NULL
,	NULL
Lin	NULL
W	NULL
,	NULL
Chang	NULL
JC	NULL
,	NULL
Kan	NULL
YW	NULL
:	NULL
Human	NULL
3-globin	NULL
gene	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
is	NULL
enhanced	NULL
by	NULL
a	NULL
distant	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:7082	NULL
,	NULL
1989	NULL
25	NULL
.	NULL

Forrester	NULL
WC	NULL
,	NULL
Novak	NULL
U	NULL
,	NULL
Gelinas	NULL
R	NULL
,	NULL
Groudine	NULL
M	NULL
:	NULL
Molecular	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
3-globin	NULL
locus	NULL
activation	NULL
region	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:5439	NULL
,	NULL
1989	NULL
26	NULL
.	NULL

Sanger	NULL
F	NULL
,	NULL
Nicklen	NULL
S	NULL
,	NULL
Coulson	NULL
AR	NULL
:	NULL
DNA	NULL
sequencing	NULL
with	NULL
chain-terminating	NULL
inhibitors	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
74:5463	NULL
,	NULL
1977	NULL
27	NULL
.	NULL

Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
1989	NULL
28	NULL
.	NULL

Bradford	NULL
MM	NULL
:	NULL
A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantita-tion	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
Biochem	NULL
72:248	NULL
,	NULL
1976	NULL
29	NULL
.	NULL

Baron	NULL
MH	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
Rapid	NULL
reprogramming	NULL
of	NULL
globin	NULL
gene	NULL
expression	NULL
in	NULL
transient	NULL
heterokaryons	NULL
.	NULL

Cell	NULL
46:591	NULL
,	NULL
1986	NULL
30	NULL
.	NULL

Enver	NULL
T	NULL
,	NULL
Brice	NULL
M	NULL
,	NULL
Karlinsky	NULL
,	NULL
J	NULL
,	NULL
Stamatoyannopoulos	NULL
G	NULL
,	NULL
Papayannopoulou	NULL
,	NULL
T	NULL
:	NULL
Developmental	NULL
regulation	NULL
of	NULL
fetal	NULL
to	NULL
adult	NULL
globin	NULL
gene	NULL
switching	NULL
in	NULL
human	NULL
fetal	NULL
erythroid	NULL
x	NULL
mouse	NULL
erythroleukemia	NULL
cell	NULL
hybrids	NULL
.	NULL

Dev	NULL
Biol	NULL
148:129	NULL
,	NULL
1991	NULL
2597	NULL
31	NULL
.	NULL

Enver	NULL
T	NULL
,	NULL
Raich	NULL
N	NULL
,	NULL
Ebens	NULL
AJ	NULL
,	NULL
Papayannopoulou	NULL
T	NULL
,	NULL
Costantini	NULL
F	NULL
,	NULL
Stamatoyannopoulos	NULL
G	NULL
:	NULL
Developmental	NULL
regulation	NULL
of	NULL
human	NULL
fetal-to-adult	NULL
globin	NULL
gene	NULL
switching	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nature	NULL
344:309	NULL
,	NULL
1990	NULL
32	NULL
.	NULL

Dignam	NULL
JD	NULL
,	NULL
Lebovitz	NULL
RM	NULL
,	NULL
Roeder	NULL
RG	NULL
:	NULL
Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
11:1475	NULL
,	NULL
1983	NULL
33	NULL
.	NULL

Miller	NULL
IJ	NULL
,	NULL
Bicker	NULL
JJ	NULL
:	NULL
;	NULL
A	NULL
novel	NULL
,	NULL
erythroid	NULL
cell-specific	NULL
murine	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
CACCC	NULL
element	NULL
and	NULL
is	NULL
related	NULL
to	NULL
the	NULL
Kriippel	NULL
family	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:2776	NULL
,	NULL
1993	NULL
34	NULL
.	NULL

Proudfoot	NULL
NJ	NULL
,	NULL
Gil	NULL
A	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
The	NULL
structure	NULL
of	NULL
the	NULL
human	NULL
zeta-globin	NULL
gene	NULL
and	NULL
a	NULL
closely	NULL
linked	NULL
,	NULL
nearly	NULL
identical	NULL
pseudogene	NULL
.	NULL

Cell	NULL
31:553	NULL
,	NULL
1982	NULL
35	NULL
.	NULL

Yu	NULL
C-Y	NULL
,	NULL
Chen	NULL
J	NULL
,	NULL
Lin	NULL
L-I	NULL
,	NULL
Tam	NULL
M	NULL
,	NULL
Shen	NULL
C-KJ	NULL
:	NULL
Cell	NULL
type-specific	NULL
protein-DNA	NULL
interactions	NULL
in	NULL
the	NULL
human	NULL
(	NULL
-globin	NULL
upstream	NULL
promoter	NULL
region	NULL
:	NULL
Displacement	NULL
of	NULL
Spl	NULL
by	NULL
the	NULL
erythroid	NULL
cell-specific	NULL
factor	NULL
NF-E1	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:282	NULL
,	NULL
1990	NULL
36	NULL
.	NULL

Wall	NULL
L	NULL
,	NULL
deBoer	NULL
E	NULL
,	NULL
Grosveld	NULL
F	NULL
:	NULL
The	NULL
human	NULL
/3-globin	NULL
gene	NULL
3	NULL
'	NULL
enhancer	NULL
contains	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
an	NULL
erythroid-specific	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
2:1089	NULL
,	NULL
1988	NULL
37	NULL
.	NULL

Proudfoot	NULL
NJ	NULL
,	NULL
Rutherford	NULL
TR	NULL
,	NULL
Partington	NULL
GA	NULL
:	NULL
Transcriptional	NULL
analysis	NULL
of	NULL
human	NULL
zeta	NULL
globin	NULL
genes	NULL
.	NULL

EMBO	NULL
J	NULL
3:1533	NULL
,	NULL
1984	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1995	NULL
85	NULL
:	NULL
2587-2597	NULL
Identification	NULL
of	NULL
a	NULL
major	NULL
positive	NULL
regulatory	NULL
element	NULL
located	NULL
5°	NULL
to	NULL
the	NULL
human	NULL
zeta-globin	NULL
gene	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
@	NULL
``	NULL
20	NULL
DE	NULL
Sabath	NULL
,	NULL
KM	NULL
Koehler	NULL
,	NULL
WQ	NULL
Yang	NULL
,	NULL
K	NULL
Patton	NULL
and	NULL
G	NULL
Stamatoyannopoulos	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/85/9/2587.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

